{"content":"<li class=\"n-box-item date-title\" data-end=\"1555559999\" data-start=\"1555473600\" data-txt=\"Monday, December 23, 2019\">Wednesday, April 17, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3451726\" data-ts=\"1555539874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451726-trevenaminus-2_7-on-filing-to-offer-up-to-50m-in-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trevena -2.7% on filing to offer up to $50M in shares</a></h4><ul>   <li>Trevena (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>) is <font color=\"red\">2.7% lower</font> after hours following a prospectus to <a href=\"https://seekingalpha.com/filing/4447690\" target=\"_blank\">offer up to $50M in shares</a>.</li>    <li>The company entered a sales agreement with H.C. Wainwright to offer up to that amount from time to time in at-the-market offerings.</li>    <li>Net proceeds could be up to $48.2M; they would be used for developing lead product candidate oliceridine and for other general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451726\" data-linked=\"Trevena -2.7% on filing to offer up to $50M in shares\" data-tweet=\"$TRVN - Trevena -2.7% on filing to offer up to $50M in shares https://seekingalpha.com/news/3451726-trevenaminus-2_7-on-filing-to-offer-up-to-50m-in-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3451726-trevenaminus-2_7-on-filing-to-offer-up-to-50m-in-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451716\" data-ts=\"1555537661\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOW\" target=\"_blank\">NOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451716-servicenowminus-2_5-after-atlassian-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ServiceNow -2.5% after Atlassian earnings</a></h4><ul><li>Atlassian peers are dropping after hours following TEAM's <a href=\"https://seekingalpha.com/news/3451655-atlassian-minus-8_5-percent-mixed-q4-outlook\" target=\"_blank\">earnings print</a> with a mixed Q4 outlook.</li><li>On the move: ServiceNow (NYSE:<a href='https://seekingalpha.com/symbol/NOW' title='ServiceNow, Inc.'>NOW</a>) <font color=\"red\">-2.5%</font>, Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) <font color=\"red\">-1.8%</font>, Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a>) <font color=\"red\">-0.5%</font>, Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>)<font color=\"red\"> -0.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451716\" data-linked=\"ServiceNow -2.5% after Atlassian earnings\" data-tweet=\"$NOW $ZEN $NOW - ServiceNow -2.5% after Atlassian earnings https://seekingalpha.com/news/3451716-servicenowminus-2_5-after-atlassian-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3451716-servicenowminus-2_5-after-atlassian-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451715\" data-ts=\"1555536990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451715-after-hours-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After hours movers and shakers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a> <font color=\"green\">+7.1%</font>. <a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/RDNT' title='RadNet, Inc.'>RDNT</a> <font color=\"green\">+2.5%</font>. <a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a> <font color=\"green\">+2.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a> <font color=\"red\">-11.5%</font>. <a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a> <font color=\"red\">-9.5%</font>. <a href='https://seekingalpha.com/symbol/PLXS' title='Plexus Corp.'>PLXS</a> <font color=\"red\">-7.1%</font><a href='https://seekingalpha.com/symbol/NOW' title='ServiceNow, Inc.'>NOW</a> <font color=\"red\">-2.3%</font>. <a href='https://seekingalpha.com/symbol/AKRX' title='Akorn, Inc.'>AKRX</a> <font color=\"red\">-2.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451715\" data-linked=\"After hours movers and shakers\" data-tweet=\"$URI $LVS $RDNT - After hours movers and shakers https://seekingalpha.com/news/3451715-after-hours-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451715-after-hours-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451714\" data-ts=\"1555536876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451714-sleep-number-shares-sink-q1-sales-margin-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sleep Number shares sink as Q1 sales, margin disappoint</a></h4><ul><li>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>) <font color=\"red\">-12%</font> after-hours as <a href=\"https://seekingalpha.com/news/3451640-sleep-number-beats-0_06-misses-revenue\" target=\"_blank\">Q1 earnings</a> top estimates but comparable sales and gross margin miss expectations.</li><li>SNBR reiterates full-year guidance for earnings and revenues even after Q1 profit beat estimates, seeing EPS of $2.25-$2.75 vs. $2.47 analyst consensus and revenue growth of 6%-10%, which computes to $1.62B-$1.68B vs. $1.64B consensus.</li><li>Comp sales rose 5% for the quarter vs. 6.2% consensus estimate and gross margin of 61.5% fell just shy of 61.9% consensus.</li><li>Other mattress firms on watch include <a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International, Inc.'>TPX</a>, <a href='https://seekingalpha.com/symbol/LEG' title='Leggett & Platt, Incorporated'>LEG</a>, <a href='https://seekingalpha.com/symbol/CULP' title='Culp, Inc.'>CULP</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451714\" data-linked=\"Sleep Number shares sink as Q1 sales, margin disappoint\" data-tweet=\"$SNBR $TPX $LEG - Sleep Number shares sink as Q1 sales, margin disappoint https://seekingalpha.com/news/3451714-sleep-number-shares-sink-q1-sales-margin-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3451714-sleep-number-shares-sink-q1-sales-margin-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451712\" data-ts=\"1555536354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451712-mustang-bio-shares-triple-in-price-on-new-bubble-boy-therapy-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mustang Bio shares triple in price on new &#39;bubble boy&#39; therapy data</a></h4><ul>   <li>Mustang Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a>) has tripled up, <font color=\"green\">jumping 199%</font> after hours, after <a href=\"https://seekingalpha.com/pr/17480535-st-jude-children-s-research-hospital-publishes-results-lentiviral-gene-therapy-treatment\" target=\"_blank\">releasing new data</a> from a phase 1/2 clinical trial.</li>    <li>The trial is of a lentiviral gene therapy for treating newly diagnosed infants with X-linked Severe Combined Immunodeficiency -- popularly known as bubble boy disease.</li>    <li>Mustang will develop the therapy in conjunction with St. Jude Children's Research Hospital as MB-107.</li>    <li>Ten infants were treated with the therapy and the data covers eight who were followed for a median of 16.4 months: Bone marrow harvest, busulfan conditioning and cell infusion were well tolerated; in seven cases, normalization of CD3+, CD4+ and CD4+ naïve T-cell and natural killer cell numbers came in 3-4 months; all patients cleared previous infections; and seven of the eight developed normal IgM levels.</li>    <li>Fortress Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/FBIO' title='Fortress Biotech, Inc.'>FBIO</a>), which owns a 38% stake in Mustang Bio, is <font color=\"green\">up 91.8%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451712\" data-linked=\"Mustang Bio shares triple in price on new &#39;bubble boy&#39; therapy data\" data-tweet=\"$MBIO $FBIO - Mustang Bio shares triple in price on new &#39;bubble boy&#39; therapy data https://seekingalpha.com/news/3451712-mustang-bio-shares-triple-in-price-on-new-bubble-boy-therapy-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3451712-mustang-bio-shares-triple-in-price-on-new-bubble-boy-therapy-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451711\" data-ts=\"1555536079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451711-canopy-growth-near-deal-for-acreage-holdings-bloomberg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth near deal for Acreage Holdings - Bloomberg</a></h4><ul><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) has been looking to get into the U.S. market - where cannabis remains illegal at the national level - and it may have found a way with Acreage Holdings (<a href='https://seekingalpha.com/symbol/ACRGF' title='Acreage Holdings, Inc.'>OTCQX:ACRGF</a>).</li><li><a href=\"https://pbs.twimg.com/media/D4YlQSmW4AAQc1x.jpg:large\" target=\"_blank\">According to the report</a>, a merger deal could be announced this week.</li><li>ACRGF was <font color=\"green\">up 9.14%</font> in the regular session today. CGC <font color=\"green\">rose 2.8%</font>, and is <font color=\"green\">up another 2.7%</font> in after hours action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451711\" data-linked=\"Canopy Growth near deal for Acreage Holdings - Bloomberg\" data-tweet=\"$CGC $ACRGF - Canopy Growth near deal for Acreage Holdings - Bloomberg https://seekingalpha.com/news/3451711-canopy-growth-near-deal-for-acreage-holdings-bloomberg?source=tweet\" data-url=\"https://seekingalpha.com/news/3451711-canopy-growth-near-deal-for-acreage-holdings-bloomberg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>146&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451710\" data-ts=\"1555535950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPOR\" target=\"_blank\">GPOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451710-gulfports-q1-production-ticks-lower-on-track-for-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gulfport&#39;s Q1 production ticks lower but on track for full-year guidance</a></h4><ul><li>Gulfport Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a>) <font color=\"red\">-1.5%</font> after-hours as it reports <a href=\"https://seekingalpha.com/pr/17480360-gulfport-energy-corporation-provides-first-quarter-2019-production-pricing-schedules-first\" target=\"_blank\">Q1 net production fell 2% Y/Y</a> to average 1.26B cfe/day, with a net daily production mix comprised of ~90% natural gas, 7% natural gas liquids and 3% oil.</li><li>During Q1, GPOR says it ran on average 3.4 horizontal drilling rigs and 4.4 completion crews in total across its Utica Shale and SCOOP assets.</li><li>Average realized prices for the quarter were $2.54/Mcf of natural gas vs. $2.35 in the year-ago quarter, $52.35/bbl of oil from $48.27 a year ago, and $0.52/gal of  NGL vs. $0.75 last year, resulting in a total equivalent price of $2.82/Mcfe vs. $2.81 a year ago.</li><li>GPOR says it remains on track to meet previous FY 2019 production guidance of 1.36B-1.4B cfe/day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451710\" data-linked=\"Gulfport&#39;s Q1 production ticks lower but on track for full-year guidance\" data-tweet=\"$GPOR - Gulfport&#39;s Q1 production ticks lower but on track for full-year guidance https://seekingalpha.com/news/3451710-gulfports-q1-production-ticks-lower-on-track-for-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3451710-gulfports-q1-production-ticks-lower-on-track-for-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451690\" data-ts=\"1555533929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451690-e-tradeplus-4-after-posting-record-revenues-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E-Trade +4% after posting record revenues in Q1</a></h4><ul>   <li>E-Trade Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>) is <font color=\"green\">up 4%</font> postmarket following a solid beat in its Q1 results after it logged record net revenue and operating margin.</li>    <li>GAAP EPS of $1.09 included a net benefit of $0.08/share tied to provisions for loan losses and communications expense.</li>    <li>Revenues rose 6.6% led by strength in interest income. The company drew a return on common equity (adjusted) of 18%.</li>    <li>Average interest-earning assets were $61B, with a net interest margin of 323 basis points.</li>    <li>Daily average revenue trades were 279,000, down 7%.</li>    <li>Revenue breakdown: Net interest income, $492M (up 10.6%); Commissions, $122M (down 10.9%); Fees and service charges, $118M (up 12.4%); gains on securities and other, $11M (up 10%); Other revenue, $12M (up 9.1%).</li>    <li>Cash and equivalents are down to $523M from $2.33B as of Dec. 31.</li>    <li><a href=\"https://cc.callinfo.com/registration/#/?meeting=13n9mzzwnuw4c&amp;campaign=1ue0oys0d0ksc\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451633-e-trade-financial-beats-0_08-beats-revenue\" target=\"_blank\">E*TRADE Financial beats by $0.08, beats on revenue</a> (Apr. 17 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17480381-e-trade-financial-corporation-announces-first-quarter-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3451690\" data-linked=\"E-Trade +4% after posting record revenues in Q1\" data-tweet=\"$ETFC - E-Trade +4% after posting record revenues in Q1 https://seekingalpha.com/news/3451690-e-tradeplus-4-after-posting-record-revenues-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3451690-e-tradeplus-4-after-posting-record-revenues-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451681\" data-ts=\"1555533388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLXS\" target=\"_blank\">PLXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451681-plexusminus-5-on-mixed-q2-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plexus -5% on mixed Q2, outlook</a></h4><ul><li>Plexus (NASDAQ:<a href='https://seekingalpha.com/symbol/PLXS' title='Plexus Corp.'>PLXS</a>) <font color=\"red\">drops 5.2%</font> on mixed Q2 results that beat revenue estimates with 13% Y/Y growth but missed on EPS.</li><li>Q3 guidance has in-line revenue from $760M to $800M and downside EPS from $0.89 to $0.90 (consensus: $0.93).</li><li>Key management quote: \"As we look to the fiscal third quarter, we expect weakness in our Communications sector to offset anticipated growth in our Aerospace/Defense and Healthcare/Life Sciences sectors.\"</li><li>Earnings call is tomorrow morning at 8:30 AM ET with a webcast <a href=\"https://plexus.gcs-web.com/events-and-presentations/upcoming-events\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17480448-plexus-announces-fiscal-second-quarter-2019-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451658-plexus-misses-0_05-beats-revenue\" target=\"_blank\">Plexus misses by $0.05, beats on revenue</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451681\" data-linked=\"Plexus -5% on mixed Q2, outlook\" data-tweet=\"$PLXS - Plexus -5% on mixed Q2, outlook https://seekingalpha.com/news/3451681-plexusminus-5-on-mixed-q2-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3451681-plexusminus-5-on-mixed-q2-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451680\" data-ts=\"1555533364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451680-alcoas-q1-ebitda-drops-39-trims-aluminum-demand-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa&#39;s Q1 EBITDA drops 39%; trims aluminum demand outlook</a></h4><ul><li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>) <font color=\"red\">-2.2%</font> after-hours following a larger than forecast <a href=\"https://seekingalpha.com/news/3451648-alcoa-misses-0_10-misses-revenue\" target=\"_blank\">Q1 loss</a> and a 12% Y/Y decline in revenues to $2.72B.</li><li>Alcoa reports Q1 adjusted EBITDA of $467M, a 39% sequential decrease, primarily due to lower alumina and aluminum prices.</li><li>The company forecasts a global aluminum deficit for FY 2019 of 1.5M-1.9M mt, down from last quarter's full-year outlook of 1.7M-2.1M mt, and estimates 2019 global aluminum demand growth of 2%-3%, down from guidance of 3%-4% in the prior quarter, mostly due to lower demand growth in China, especially in the transportation and electrical sectors.</li><li>For Q2, Alcoa expects favorable improvements from its third-party energy sales in Brazil and lower alumina costs to its aluminum segment, as well as moderate benefits from declines in raw material prices, primarily in the alumina segment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451680\" data-linked=\"Alcoa&#39;s Q1 EBITDA drops 39%; trims aluminum demand outlook\" data-tweet=\"$AA - Alcoa&#39;s Q1 EBITDA drops 39%; trims aluminum demand outlook https://seekingalpha.com/news/3451680-alcoas-q1-ebitda-drops-39-trims-aluminum-demand-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3451680-alcoas-q1-ebitda-drops-39-trims-aluminum-demand-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451671\" data-ts=\"1555533023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451671-macau-names-gain-after-las-vegas-sands-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau names gain after Las Vegas Sands results</a></h4><ul> <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>), MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) and Melco Crown &amp; Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited'>MLCO</a>) are all up between <font color=\"green\">1.0% and 1.2%</font> in the AH session after Las Vegas Sands posts strong results in Macau for Q1.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3451635-las-vegas-sands-beats-0_04-beats-revenue\" target=\"_blank\">Las Vegas Sands beats by $0.04, beats on revenue</a> (April 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451651-macau-results-lift-las-vegas-sands\" target=\"_blank\">Macau results lift Las Vegas Sands</a> (April 17)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451671\" data-linked=\"Macau names gain after Las Vegas Sands results\" data-tweet=\"$WYNN $MGM $MLCO - Macau names gain after Las Vegas Sands results https://seekingalpha.com/news/3451671-macau-names-gain-after-las-vegas-sands-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3451671-macau-names-gain-after-las-vegas-sands-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451669\" data-ts=\"1555532781\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLNW\" target=\"_blank\">LLNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451669-limelight-networksminus-14_5-q1-trails-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Limelight Networks -14.5% as Q1 trails expectations</a></h4><ul>   <li>Limelight Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a>) is <font color=\"red\">14.5% lower</font> after hours folowing a miss on top and bottom lines in its Q1 earnings report, as the company looked toward improvement for the rest of the year.</li>    <li>Revenues fell nearly 17% and fell short of expectations, while the company lost $5.1M on a non-GAAP basis vs. break-even expectations.</li>    <li>Adjusted EBITDA was -$0.6M as well, vs. a positive $11M a year ago.</li>    <li>The company expected a low point for the year in Q1: \"Results were largely in line with our expectations as we invested heavily in opportunities that we believe will yield significant revenue in the second half of 2019. With the first quarter now behind us, we expect 2019 to show meaningful sequential improvement going forward, and our year\u2013over-year growth rate in both percentages and actual dollars should be our best in many years,\" says CEO Robert Lento.</li>    <li>It's reiterated full-year guidance to revenue of $215M-$225M, non-GAAP EPS of $0.10-$0.20, EBITDA of $30M-$40M, and capital expenditures of $20M-$24M.</li>    <li><a href=\"https://services.choruscall.com/links/llnw190417.html\" target=\"_blank\">Conference call</a> to come at 4:30 p.m.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451624-limelight-networks-misses-0_04-misses-revenue\" target=\"_blank\">Limelight Networks misses by $0.04, misses on revenue</a> (Apr. 17 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17480352-limelight-networks-reports-financial-results-first-quarter-2019\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3451669\" data-linked=\"Limelight Networks -14.5% as Q1 trails expectations\" data-tweet=\"$LLNW - Limelight Networks -14.5% as Q1 trails expectations https://seekingalpha.com/news/3451669-limelight-networksminus-14_5-q1-trails-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3451669-limelight-networksminus-14_5-q1-trails-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451668\" data-ts=\"1555532764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451668-margins-sink-pier-1-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins sink at Pier 1 Imports</a></h4><ul> <li>Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports, Inc.'>PIR</a>) is down another <font color=\"red\">5.83%</font> to $0.58 after posting a wider loss in Q1 than anticipated.</li> <li>Gross margin plummeted to 25.9% of sales vs. 37.0% a year ago and 31.8% consensus. Management blamed \"execution\" issues once again.</li> <li>The company recorded an adjusted EBITDA loss of $52M for the quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451657-pier-1-imports-misses-revenue\" target=\"_blank\">Pier 1 Imports misses on revenue</a> (April 17)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451668\" data-linked=\"Margins sink at Pier 1 Imports\" data-tweet=\"$PIR - Margins sink at Pier 1 Imports https://seekingalpha.com/news/3451668-margins-sink-pier-1-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3451668-margins-sink-pier-1-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451662\" data-ts=\"1555532540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451662-united-rentalsplus-5-after-earnings-beat-reaffirmed-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals +5% after earnings beat, reaffirmed outlook</a></h4><ul>  <li>United Rentals (NYSE:<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>) trades up after topping <a href=\"https://seekingalpha.com/news/3451652-united-rentals-beats-0_27-beats-revenue\" target=\"_blank\">Q1</a> estimates.</li>  <li>Adjusted EBITDA increased 18.1% to $921M vs. $910M consensus.</li> <li>The company's adjusted EBITDA margin fell 150 bps to 3.1% of sales as acquisitions factored in.</li>   <li>Looking ahead, United Rentals expects 2019 revenue of $9.15B to $9.55B and adjusted EBITDA of $4.35B to $4.55B. Free cash flow of $1.3B to $1.5B is anticipated.</li> <li>CEO update: \"By reaffirming our guidance, we\u2019re emphasizing our confidence in the cycle. The year is unfolding as we expected - customer sentiment remains positive, and feedback from the field points to healthy end-market activity.\"</li> <li>URI <font color=\"green\">+5.0%</font> AH to $132.09.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451662\" data-linked=\"United Rentals +5% after earnings beat, reaffirmed outlook\" data-tweet=\"$URI - United Rentals +5% after earnings beat, reaffirmed outlook https://seekingalpha.com/news/3451662-united-rentalsplus-5-after-earnings-beat-reaffirmed-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3451662-united-rentalsplus-5-after-earnings-beat-reaffirmed-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451655\" data-ts=\"1555532339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAM\" target=\"_blank\">TEAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451655-atlassianminus-8_5-on-mixed-q4-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlassian -8.5% on mixed Q4 outlook</a></h4><ul><li>Atlassian (NASDAQ:<a href='https://seekingalpha.com/symbol/TEAM' title='Atlassian Corporation Plc'>TEAM</a>) <font color=\"red\">plunges 8.5%</font> after reporting Q3 beats and 38% Y/Y revenue growth with Q4 guidance that has upside revenue from $329M to $331M (consensus: $327.58M) but misses with $0.16 EPS (consensus: $0.19).</li><li>FY19 guidance has revenue from $1.205B to $1.207B (consensus: $1.2B) and EPS of about $0.82 (consensus: $0.81)</li><li>Non-IFRS operating margin was 19% compared to 17% last year.</li><li>Operating cash flow totaled $133.3M and FCF was $127.1M.</li><li>TEAM added 5,803 net new customers in the quarter.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.atlassian.com&amp;esheet=51971295&amp;newsitemid=20190417005919&amp;lan=en-US&amp;anchor=https%3A%2F%2Finvestors.atlassian.com&amp;index=3&amp;md5=9d0bb44dd06c42f05f96c3a675f4c567\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17480362-atlassian-announces-third-quarter-fiscal-year-2019-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451629-atlassian-beats-0_03-beats-revenue\" target=\"_blank\">Atlassian beats by $0.03, beats on revenue</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451655\" data-linked=\"Atlassian -8.5% on mixed Q4 outlook\" data-tweet=\"$TEAM - Atlassian -8.5% on mixed Q4 outlook https://seekingalpha.com/news/3451655-atlassianminus-8_5-on-mixed-q4-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3451655-atlassianminus-8_5-on-mixed-q4-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451652\" data-ts=\"1555532222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451652-united-rentals-beats-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Rentals beats by $0.27, beats on revenue</a></h4><ul><li>United Rentals (NYSE:<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a>): Q1 Non-GAAP EPS of $3.31 <span style=\"color:green\">beats by $0.27</span>; GAAP EPS of $2.19.</li><li>Revenue of $2.12B (+22.5% Y/Y) <font color=\"green\">beats by $70M</font>.</li><li>Shares <font color=\"green\">+2.18%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17480433-united-rentals-announces-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451652\" data-linked=\"United Rentals beats by $0.27, beats on revenue\" data-tweet=\"$URI - United Rentals beats by $0.27, beats on revenue https://seekingalpha.com/news/3451652-united-rentals-beats-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3451652-united-rentals-beats-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451651\" data-ts=\"1555532208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVS\" target=\"_blank\">LVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451651-macau-results-lift-las-vegas-sands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau results lift Las Vegas Sands</a></h4><ul>   <li>Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) trades higher after a strong operating performance in Macau during <a href=\"https://seekingalpha.com/pr/17480397-las-vegas-sands-reports-first-quarter-2019-results\" target=\"_blank\">Q1</a> offset decreases in rolling Chip win percentages and volume in Singapore.</li>   <li>Net income was $708M during the quarter vs. $821M a year ago.</li>  <li>The Sands China business recorded revenue growth of 8% to $2.33B vs. $2.20B consensus and property EBITDA of $858M (+8.8%) vs. $796M consensus.</li>  <li>Las Vegas properties generated revenue of $471M vs. $433M a year ago and $463M consensus. The Marine Bay Sands property generated revenue of $767M and EBITDA of $423M.</li>  <li>\"We are pleased to have delivered strong financial results in the quarter, led by consistent growth in the mass and non-gaming segments in Macao,\" says CEO Sheldon Adelson.</li>  <li>Shares of LVS are <font color=\"green\">up 4.05%</font> in AH trading to $70.64.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451635-las-vegas-sands-beats-0_04-beats-revenue\" target=\"_blank\">Las Vegas Sands beats by $0.04, beats on revenue</a> (April 17)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3451651\" data-linked=\"Macau results lift Las Vegas Sands\" data-tweet=\"$LVS - Macau results lift Las Vegas Sands https://seekingalpha.com/news/3451651-macau-results-lift-las-vegas-sands?source=tweet\" data-url=\"https://seekingalpha.com/news/3451651-macau-results-lift-las-vegas-sands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451637\" data-ts=\"1555531668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIGR\" target=\"_blank\">EIGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451637-eiger-bio-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eiger Bio readies stock offering</a></h4><ul><li>Eiger BioPharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EIGR' title='Eiger BioPharmaceuticals, Inc.'>EIGR</a>) commences a <a href=\"https://seekingalpha.com/pr/17480344-eiger-biopharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be released.</li><li>Shares are down a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451637\" data-linked=\"Eiger Bio readies stock offering\" data-tweet=\"$EIGR - Eiger Bio readies stock offering https://seekingalpha.com/news/3451637-eiger-bio-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3451637-eiger-bio-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451635\" data-ts=\"1555531636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVS\" target=\"_blank\">LVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451635-las-vegas-sands-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Las Vegas Sands beats by $0.04, beats on revenue</a></h4><ul><li>Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>): Q1 Non-GAAP EPS of $0.91 <span style=\"color:green\">beats by $0.04</span>; GAAP EPS of $0.75.</li><li>Revenue of $3.65B (+2.0% Y/Y) <font color=\"green\">beats by $160M</font>.</li><li>Shares <font color=\"green\">+3.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17480397-las-vegas-sands-reports-first-quarter-2019-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451635\" data-linked=\"Las Vegas Sands beats by $0.04, beats on revenue\" data-tweet=\"$LVS - Las Vegas Sands beats by $0.04, beats on revenue https://seekingalpha.com/news/3451635-las-vegas-sands-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3451635-las-vegas-sands-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451626\" data-ts=\"1555531493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNM\" target=\"_blank\">ATNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451626-actinium-launches-equity-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actinium launches equity offering; shares down 13% after hours</a></h4><ul><li>Actinium Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/ATNM' title='Actinium Pharmaceuticals, Inc.'>ATNM</a>) initiates a <a href=\"https://seekingalpha.com/pr/17480357-actinium-pharmaceuticals-inc-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">public offering</a> of common stock and warrants. Prices, volumes and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">13%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451626\" data-linked=\"Actinium launches equity offering; shares down 13% after hours\" data-tweet=\"$ATNM - Actinium launches equity offering; shares down 13% after hours https://seekingalpha.com/news/3451626-actinium-launches-equity-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3451626-actinium-launches-equity-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451614\" data-ts=\"1555528476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNKO\" target=\"_blank\">FNKO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451614-funkominus-4-after-cfo-resignation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Funko -4% after CFO resignation</a></h4><ul> <li>Funko (<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='red'>-4.7%</font>) trades lower after announcing that CFO Russell Nickel intends to leave the company at the end of 2019.</li><li>The company has begun its search for a replacement.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17478795-funko-announces-russell-nickel-plans-step-cfo-end-2019\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3451614\" data-linked=\"Funko -4% after CFO resignation\" data-tweet=\"$FNKO - Funko -4% after CFO resignation https://seekingalpha.com/news/3451614-funkominus-4-after-cfo-resignation?source=tweet\" data-url=\"https://seekingalpha.com/news/3451614-funkominus-4-after-cfo-resignation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451609\" data-ts=\"1555527268\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451609-technology-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology movers and shakers</a></h4><ul><li><strong>Gainers: </strong>Uxin Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+50%</font>. Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"green\">+18%</font>. QUALCOMM Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) <font color=\"green\">+13%</font>. Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo Inc.'>GOGO</a>) <font color=\"green\">+10%</font>. 21Vianet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group, Inc.'>VNET</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"red\">-27%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"red\">-17%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"red\">-14%</font>. CEVA (NASDAQ:<a href='https://seekingalpha.com/symbol/CEVA' title='CEVA, Inc.'>CEVA</a>) <font color=\"red\">-14%</font>. MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='MicroVision, Inc.'>MVIS</a>) <font color=\"red\">-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451609\" data-linked=\"Technology movers and shakers\" data-tweet=\"$UXIN $BOXL $QCOM - Technology movers and shakers https://seekingalpha.com/news/3451609-technology-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451609-technology-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451606\" data-ts=\"1555526298\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOP\" target=\"_blank\">GLOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451606-gaslog-partners-distribution-growth-running-out-of-steam-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GasLog Partners&#39; distribution growth running out of steam, analyst says</a></h4><ul><li>GasLog Partners' (<a href='https://seekingalpha.com/symbol/GLOP' title='GasLog Partners LP'>GLOP</a> <font color='red'>-9.5%</font>) plunges after Morgan Stanley <a href=\"https://thefly.com/thestreet/realmoney/index.php/GLOP;GLOGid2893396/GLOP;GLOG-GasLog-Partners-downgraded-to-Equal-Weight-from-Overweight-at-Morgan-Stanley\" target=\"_blank\">downgrades</a> shares to Equal Weight from Overweight with an $18 price target, cut from $23, believing GLOP's ability to accretively fund new dropdowns has become more challenging.</li><li>Stanley analyst Fotis Giannakoulis also says GLOP's current distribution is not fully covered by free cash flows and sees distribution capacity as reaching a plateau.</li><li>Stanley maintains its Equal Weight rating for parent GasLog (<a href='https://seekingalpha.com/symbol/GLOG' title='GasLog Ltd.'>GLOG</a> <font color='red'>-1.5%</font>) but cuts its price target to $15 from $20, noting liquefied natural gas carrier fundamentals have softened due to a rising order book coupled with the sharp decline in global LNG prices.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451606\" data-linked=\"GasLog Partners&#39; distribution growth running out of steam, analyst says\" data-tweet=\"$GLOP $GLOG - GasLog Partners&#39; distribution growth running out of steam, analyst says https://seekingalpha.com/news/3451606-gaslog-partners-distribution-growth-running-out-of-steam-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3451606-gaslog-partners-distribution-growth-running-out-of-steam-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>102&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451598\" data-ts=\"1555525103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451598-cnbc-facebook-building-entry-to-voice-assistants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Facebook building entry to voice assistants</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+0.1%</font>) is working on its own rival <a href=\"https://www.cnbc.com/2019/04/17/facebook-building-voice-assistant-to-rival-amazon-alexa-and-apple-siri.html\" target=\"_blank\">voice assistant</a> to take on Alexa, Google and Siri, CNBC says.</li>    <li>That's another project from the company's Facebook Reality Labs skunk works, according to the report.</li>    <li>Led by a team based out of Redmond, Washington, the project has been in the works since early last year, but Facebook trails a dominant lead built by Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color=\"green\">+0.3%</font>) and Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"green\">+0.7%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"green\">+0.6%</font>), and to a smaller extent Apple (<a href=\"http://seekingalpha.com/symbol/AAPL\" target=\"_blank\">AAPL</a> <font color=\"green\">+1.8%</font>).</li>    <li>It might fit a few places, the report notes: Facebook already offers its Portal video-chat device (currently equipped with Amazon's Alexa) as well as Oculus VR headsets.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451598\" data-linked=\"CNBC: Facebook building entry to voice assistants\" data-tweet=\"$GOOG $GOOGL $FB - CNBC: Facebook building entry to voice assistants https://seekingalpha.com/news/3451598-cnbc-facebook-building-entry-to-voice-assistants?source=tweet\" data-url=\"https://seekingalpha.com/news/3451598-cnbc-facebook-building-entry-to-voice-assistants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451595\" data-ts=\"1555524680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451595-ec-oks-sale-of-arcelormittal-steel-assets-in-ilva-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EC OKs sale of ArcelorMittal steel assets in Ilva deal</a></h4><ul><li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+3.4%</font>) says it <a href=\"https://www.energylivenews.com/2019/04/17/eu-approves-sale-of-arcelormittals-steel-assets-to-liberty-house/\" target=\"_blank\">received approval</a> from the European Commission for Liberty House's acquisition of the seven  European steelmaking facilities MT was required to sell to fulfill its Ilva  purchase.</li><li>The assets consist of including integrated  steelworks in Romania and Czechia as well as finishing plants in Belgium, Italy, Luxembourg and North Macedonia.</li><li>The EC says there are no longer competition concerns, with only limited overlaps between the activities of Liberty House and the  steel plants acquired.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451595\" data-linked=\"EC OKs sale of ArcelorMittal steel assets in Ilva deal\" data-tweet=\"$MT - EC OKs sale of ArcelorMittal steel assets in Ilva deal https://seekingalpha.com/news/3451595-ec-oks-sale-of-arcelormittal-steel-assets-in-ilva-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3451595-ec-oks-sale-of-arcelormittal-steel-assets-in-ilva-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451591\" data-ts=\"1555524309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451591-chinese-auto-stocks-soar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese auto stocks soar</a></h4><ul><li>Shares of Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) are <font color=\"green\">up 4.0%</font> amid <a href=\"https://www.bloomberg.com/news/articles/2019-04-17/china-auto-stocks-surge-on-speculation-license-controls-may-ease-juku4z77?utm_\" target=\"_blank\">reports</a> that China may cut down on automobile license restrictions in major cities.</li><li>Sources say new subsidies for new energy vehicles could also be instituted.</li><li>China's National Development and Reform Commission hasn't confirmed the report.</li><li>Great Wall Motors (<a href='https://seekingalpha.com/symbol/GWLLF' title='Great Wall Motor Company Limited'>OTCPK:GWLLF</a>) was <font color=\"green\">up 9.9%</font> today in Hong Kong and BYD (<a href='https://seekingalpha.com/symbol/BYDDF' title='BYD Company Limited'>OTCPK:BYDDF</a>) was <font color=\"green\">13.7% higher</font>, while Dongeng Motors (<a href='https://seekingalpha.com/symbol/DNFGF' title='Dongfeng Motor Group Company Limited'>OTCPK:DNFGF</a>, <a href='https://seekingalpha.com/symbol/DNFGY' title='Dongfeng Motor Group Company Limited'>OTCPK:DNFGY</a>) posted  a 6.2% gain. Geely Automobile <font color=\"green\">soared 12.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451591\" data-linked=\"Chinese auto stocks soar\" data-tweet=\"$NIO $GWLLF $BYDDF - Chinese auto stocks soar https://seekingalpha.com/news/3451591-chinese-auto-stocks-soar?source=tweet\" data-url=\"https://seekingalpha.com/news/3451591-chinese-auto-stocks-soar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451586\" data-ts=\"1555524098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451586-sibanye-gold-and-amyris-among-energy-materials-gainers-roan-resources-and-key-energy-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye Gold and Amyris among energy/materials gainers; Roan Resources and Key Energy Services among loser</a></h4><ul><li><b>Gainers: </b>Piedmont Lithium (NASDAQ:<a href='https://seekingalpha.com/symbol/PLL' title='Piedmont Lithium Limited'>PLL</a>) <font color=\"green\">+13%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"green\">+9%</font>. Gulf Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/GURE' title='Gulf Resources, Inc.'>GURE</a>) <font color=\"green\">+7%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+7%</font>. SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals Inc.'>SILV</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"red\">-14%</font>. Roan Resources (NYSE:<a href='https://seekingalpha.com/symbol/ROAN' title='Roan Resources, Inc.'>ROAN</a>) <font color=\"red\">-8%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451586\" data-linked=\"Sibanye Gold and Amyris among energy/materials gainers; Roan Resources and Key Energy Services among loser\" data-tweet=\"$PLL $SBGL $GURE - Sibanye Gold and Amyris among energy/materials gainers; Roan Resources and Key Energy Services among loser https://seekingalpha.com/news/3451586-sibanye-gold-and-amyris-among-energy-materials-gainers-roan-resources-and-key-energy-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3451586-sibanye-gold-and-amyris-among-energy-materials-gainers-roan-resources-and-key-energy-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451585\" data-ts=\"1555523889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451585-doj-charges-31-docs-for-over-prescribing-opioids\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOJ charges 31 docs for over-prescribing opioids</a></h4><ul><li>The U.S. Depart of Justice has <a href=\"https://www.statnews.com/2019/04/17/doctors-charged-illegal-prescription-opioid-crackdown/?utm_content=bufferd454c&amp;utm_medium=social&amp;utm_source=twitter&amp;utm_campaign=twitter_organic\" target=\"_blank\">charged 60 people</a>, including 31 physicians, with illegally prescribing and distributing opioid painkillers. The DOJ claims that the group, which includes 53 medical professionals, are tied to ~350K prescriptions and 32M pills.</li><li>The operation, launched by the Trump administration last year, was conducted by the federal Appalachian Regional Prescription Opioid Strike Force.</li><li>Opioid-related tickers: Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"red\">-5.6%</font>); INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='INSYS Therapeutics, Inc.'>INSY</a> <font color=\"red\">-5.2%</font>); Titan Pharmaceuticals (<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color=\"red\">-2.4%</font>); Dr. Reddy's Laboratories (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color=\"green\">+0.6%</font>); Mallinckrodt (<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a> <font color=\"red\">-10.8%</font>); Perrigo (<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company plc'>PRGO</a> <font color=\"red\">-1.7%</font>); AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-3.1%</font>); Opiant Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color=\"green\">+1.4%</font>); Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-5.2%</font>); Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-3.5%</font>); Alkermes plc (<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color=\"red\">-3.9%</font>); Amphastar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar Pharmaceuticals, Inc.'>AMPH</a> <font color=\"red\">-4.2%</font>); Cassava Sciences (<a href='https://seekingalpha.com/symbol/SAVA' title='Cassava Sciences, Inc.'>SAVA</a> <font color=\"green\">+1.8%</font>); BioDelivery Sciences (<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color=\"red\">-6%</font>); Assertio Therapeutics (<a href='https://seekingalpha.com/symbol/ASRT' title='Assertio Therapeutics, Inc.'>ASRT</a> <font color=\"red\">-7.6%</font>); Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"red\">-5.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451585\" data-linked=\"DOJ charges 31 docs for over-prescribing opioids\" data-tweet=\"$ENDP $INSY $TTNP - DOJ charges 31 docs for over-prescribing opioids https://seekingalpha.com/news/3451585-doj-charges-31-docs-for-over-prescribing-opioids?source=tweet\" data-url=\"https://seekingalpha.com/news/3451585-doj-charges-31-docs-for-over-prescribing-opioids\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451566\" data-ts=\"1555522361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451566-citi-sprint-50-worst-case-downside-no-t-mobile-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi: Sprint has 50% worst-case downside if no T-Mobile merger</a></h4><ul><li>With <a href=\"https://seekingalpha.com/news/3451492-sprint-t-mobile-fallout-carriers-lower-spectrum-holders-rise\" target=\"_blank\">speculation again rife</a> about the potential success of a merger of Sprint (<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a> <font color='red'>-5.7%</font>) with T-Mobile (<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a> <font color='red'>-2.2%</font>), Citi says its bear-case scenario in case of a breakdown values Sprint at $3/share -- 50% downside from yesterday's close.</li><li>The firm still likes T-Mobile deal or no deal and is bullish on AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='red'>-0.4%</font>) and Verizon (<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a> <font color='red'>-1.3%</font>) even in a four player market, but \"We believe Sprint would need to formulate a plan to improve marketing effectiveness and sustain elevated network investment, while managing net debt leverage and FCF needs.\"</li><li>Meanwhile, TDS (<a href='https://seekingalpha.com/symbol/TDS' title='Telephone and Data Systems, Inc.'>TDS</a> <font color='red'>-3.3%</font>) and U.S. Cellular (<a href='https://seekingalpha.com/symbol/USM' title='United States Cellular Corporation'>USM</a> <font color='red'>-3.7%</font>) might benefit from a measured promotional environment or as deal targets for scale hunters like Sprint or T-Mobile, the firm says, and upside for tower firms like American Tower (<a href='https://seekingalpha.com/symbol/AMT' title='American Tower Corporation &#40;REIT&#41;'>AMT</a> <font color='red'>-0.8%</font>), Crown Castle (<a href='https://seekingalpha.com/symbol/CCI' title='Crown Castle International Corp. &#40;REIT&#41;'>CCI</a> <font color='red'>-0.7%</font>) or SBA Communications (<a href='https://seekingalpha.com/symbol/SBAC' title='SBA Communications Corporation'>SBAC</a> <font color='red'>-0.6%</font>) might be limited even if the merger fails since they're already elevated. (h/t Bloomberg)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451566\" data-linked=\"Citi: Sprint has 50% worst-case downside if no T-Mobile merger\" data-tweet=\"$S $TMUS $T - Citi: Sprint has 50% worst-case downside if no T-Mobile merger https://seekingalpha.com/news/3451566-citi-sprint-50-worst-case-downside-no-t-mobile-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3451566-citi-sprint-50-worst-case-downside-no-t-mobile-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451552\" data-ts=\"1555521747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAJ\" target=\"_blank\">CAJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451552-canonminus-1_4-on-expected-outlook-cut-nar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canon -1.4% on expected outlook cut - NAR</a></h4><ul><li>Canon (NYSE:<a href='https://seekingalpha.com/symbol/CAJ' title='Canon Inc.'>CAJ</a>)<font color=\"red\"> drops 1.4%</font> after <em><a href=\"https://asia.nikkei.com/Business/Companies/Canon-to-cut-profit-outlook-as-phones-sap-camera-market\" target=\"_blank\">Nikkei Asian Review</a></em> sources say the company will lower its FY19 operating profit outlook to about $447M below the current forecast.</li><li>The downgrade results from the weakening digital camera market as smartphone cameras become more sophisticated.</li><li>Canon reports Q1 results on April 24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451552\" data-linked=\"Canon -1.4% on expected outlook cut - NAR\" data-tweet=\"$CAJ - Canon -1.4% on expected outlook cut - NAR https://seekingalpha.com/news/3451552-canonminus-1_4-on-expected-outlook-cut-nar?source=tweet\" data-url=\"https://seekingalpha.com/news/3451552-canonminus-1_4-on-expected-outlook-cut-nar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451547\" data-ts=\"1555520896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451547-hollysys-automation-technologies-and-abb-among-industrial-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hollysys Automation Technologies and ABB among industrial gainers</a></h4><ul><li><b>Gainers: </b>Hollysys Automation Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLI' title='Hollysys Automation Technologies Ltd.'>HOLI</a>) <font color=\"green\">+7%</font>. Orion Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/ORN' title='Orion Group Holdings, Inc.'>ORN</a>) <font color=\"green\">+7%</font>. Luxfer Holdings (NYSE:<a href='https://seekingalpha.com/symbol/LXFR' title='Luxfer Holdings PLC'>LXFR</a>) <font color=\"green\">+6%</font>. ABB (NYSE:<a href='https://seekingalpha.com/symbol/ABB' title='ABB Ltd'>ABB</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3451547\" data-linked=\"Hollysys Automation Technologies and ABB among industrial gainers\" data-tweet=\"$HOLI $ORN $LXFR - Hollysys Automation Technologies and ABB among industrial gainers https://seekingalpha.com/news/3451547-hollysys-automation-technologies-and-abb-among-industrial-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451547-hollysys-automation-technologies-and-abb-among-industrial-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451544\" data-ts=\"1555520569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451544-atlas-financial-holdings-and-banco-macro-only-financial-gainers-ehealth-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlas Financial Holdings and Banco Macro the only financial gainers; eHealth leads losers</a></h4><ul><li><b>Gainers:</b> Atlas Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AFH' title='Atlas Financial Holdings, Inc.'>AFH</a>) <font color=\"green\">+10%</font>. Banco Macro (NYSE:<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"red\">-20%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-11%</font>. United Financial Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/UBNK' title='United Financial Bancorp, Inc.'>UBNK</a>) <font color=\"red\">-11%</font>. The Bank of New York Mellon (NYSE:<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a>) <font color=\"red\">-9%</font>. 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance, Inc.'>QFIN</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451544\" data-linked=\"Atlas Financial Holdings and Banco Macro the only financial gainers; eHealth leads losers\" data-tweet=\"$AFH $BMA $EHTH - Atlas Financial Holdings and Banco Macro the only financial gainers; eHealth leads losers https://seekingalpha.com/news/3451544-atlas-financial-holdings-and-banco-macro-only-financial-gainers-ehealth-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451544-atlas-financial-holdings-and-banco-macro-only-financial-gainers-ehealth-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451536\" data-ts=\"1555520365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBI\" target=\"_blank\">XBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451536-drugmaker-selloff-intensifies-on-d-c-pricing-headwinds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drugmaker selloff intensifies on D.C. pricing headwinds</a></h4><ul><li>Investors in biotechs and biopharma firms appear to have intensified their profit-taking after the Q1 run-up, stoked, no doubt, from the sour mood in Congress over high drug prices and the Trump administration's stated priority to tackle the problem.</li><li>The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color=\"red\">-4.6%</font>) is down on almost 75% higher volume while the SPDR S&amp;P Pharmaceuticals ETF (<a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a> <font color=\"red\">-3.2%</font>) is down on almost 33% higher volume (albeit on turnover of only 72K shares). Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"green\">+1.4%</font>) is the only one above water.</li><li>Selected tickers: Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-1%</font>); Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-2.2%</font>); AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-2.7%</font>); Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-4.1%</font>); Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.7%</font>); Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"red\">-3%</font>); Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-2.5%</font>); Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-2.4%</font>); Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-3.2%</font>); GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"red\">-0.4%</font>); Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-2.2%</font>); AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-0.7%</font>); Bausch Health (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"red\">-3.4%</font>); Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"red\">-5.3%</font>); Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-1.7%</font>); Seattle Genetics (<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color=\"red\">-5%</font>); CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"red\">-8.1%</font>); Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine, Inc.'>EDIT</a> <font color=\"red\">-5.6%</font>); Intellia Therapeutics (<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics, Inc.'>NTLA</a> <font color=\"red\">-7.9%</font>); Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"red\">-5%</font>); Incyte (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"red\">-3.1%</font>); Intrexon (<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corporation'>XON</a> <font color=\"red\">-10.7%</font>); Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color=\"red\">-7.1%</font>); BioMarin Pharmaceutical (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"red\">-6%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451536\" data-linked=\"Drugmaker selloff intensifies on D.C. pricing headwinds\" data-tweet=\"$XBI $XPH $BIIB - Drugmaker selloff intensifies on D.C. pricing headwinds https://seekingalpha.com/news/3451536-drugmaker-selloff-intensifies-on-d-c-pricing-headwinds?source=tweet\" data-url=\"https://seekingalpha.com/news/3451536-drugmaker-selloff-intensifies-on-d-c-pricing-headwinds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>245&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451537\" data-ts=\"1555519857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451537-new-tigr-ions-and-ehth-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NEW, TIGR, IONS and EHTH among notable midday movers</a></h4><ul><li><strong>Gainers</strong>: Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+49%</font>. Smart &amp; Final Stores (NYSE:<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores, Inc.'>SFS</a>) <font color=\"green\">+20%</font>. Boxlight (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"green\">+18%</font>. Puxin (NYSE:<a href='https://seekingalpha.com/symbol/NEW' title='Puxin Limited'>NEW</a>) <font color=\"green\">+11%. </font>QUALCOMM (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) <font color=\"green\">+10%</font>. J. C. Penney Company (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J. C. Penney Company, Inc.'>JCP</a>) <font color=\"green\">+10%</font>. VIVUS (NASDAQ:<a href='https://seekingalpha.com/symbol/VVUS' title='VIVUS, Inc.'>VVUS</a>) <font color=\"green\">+10%</font>. Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo Inc.'>GOGO</a>) <font color=\"green\">+9%</font>. Piedmont Lithium (NASDAQ:<a href='https://seekingalpha.com/symbol/PLL' title='Piedmont Lithium Limited'>PLL</a>) <font color=\"green\">+9%</font>. Marten Transport, Ltd. (NASDAQ:<a href='https://seekingalpha.com/symbol/MRTN' title='Marten Transport, Ltd.'>MRTN</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers</strong>: UP Fintech Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TIGR' title='UP Fintech Holding Limited'>TIGR</a>) <font color=\"red\">-26%</font>. eHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) <font color=\"red\">-21%</font>. Chesapeake Granite Wash Trust (NYSE:<a href='https://seekingalpha.com/symbol/CHKR' title='Chesapeake Granite Wash Trust'>CHKR</a>) <font color=\"red\">-17%</font>. CEVA (NASDAQ:<a href='https://seekingalpha.com/symbol/CEVA' title='CEVA, Inc.'>CEVA</a>) <font color=\"red\">-16%</font>. MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='MicroVision, Inc.'>MVIS</a>) <font color=\"red\">-16%</font>. EDAP TMS S.A. (NASDAQ:<a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a>) <font color=\"red\">-12%</font>. Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) <font color=\"red\">-13%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"red\">-13%</font>. Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) <font color=\"red\">-12%</font>. STAAR Surgical (NASDAQ:<a href='https://seekingalpha.com/symbol/STAA' title='STAAR Surgical Company'>STAA</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451537\" data-linked=\"NEW, TIGR, IONS and EHTH among notable midday movers\" data-tweet=\"$UXIN $SFS $BOXL - NEW, TIGR, IONS and EHTH among notable midday movers https://seekingalpha.com/news/3451537-new-tigr-ions-and-ehth-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451537-new-tigr-ions-and-ehth-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451533\" data-ts=\"1555518948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451533-sibanye-stillwater-says-five-month-gold-strike-over\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye-Stillwater says five-month gold strike over</a></h4><ul><li>Sibanye-Stillwater (<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color=\"green\">+7.9%</font>) surges on news that the <a href=\"https://www.businesslive.co.za/bd/companies/mining/2019-04-17-sibanye-stillwater-says-five-month-gold-strike-is-over/\" target=\"_blank\">five-month gold strike has ended</a>, as the AMCU union signs the same deal other unions reached last November.</li><li>As part of the deal, AMCU agrees to sign the three-year wage agreement previously signed by three other unions, while SBGL will pay 4K South African rand in cash to each of the union's 14K striking  members and a soft 5K rand loan to be repaid over 12 months.</li><li>SBGL has run up ~1.5B rand in losses because of the labor action called by AMCU in  November as a result of the pay dispute.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451533\" data-linked=\"Sibanye-Stillwater says five-month gold strike over\" data-tweet=\"$SBGL - Sibanye-Stillwater says five-month gold strike over https://seekingalpha.com/news/3451533-sibanye-stillwater-says-five-month-gold-strike-over?source=tweet\" data-url=\"https://seekingalpha.com/news/3451533-sibanye-stillwater-says-five-month-gold-strike-over\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451526\" data-ts=\"1555517437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451526-fox-business-sprint-t-mobile-approval-odds-closer-to-50minus-50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fox Business: Sprint/T-Mobile approval odds closer to 50-50</a></h4><ul>    <li>A small blip up briefly pared losses for Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) and T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) as Fox's Charlie Gasparino says a source close to DOJ thinking called a <i>WSJ</i> story about merger doubts \"<a href=\"https://twitter.com/CGasparino/status/1118544004818382848\" target=\"_blank\">irresponsible</a>.\"</li>    <li>He says sources close to the deal give it more 50-50 odds.</li>    <li>While T-Mobile's at its highest point since the first half-hour of trading (now <font color=\"red\">down just 2.3%</font>), Sprint has resumed downward, now <font color=\"red\">-5.6%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451492-sprint-t-mobile-fallout-carriers-lower-spectrum-holders-rise\" target=\"_blank\">Sprint/T-Mobile fallout: Carriers lower, spectrum holders rise</a> (Apr. 17 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451526\" data-linked=\"Fox Business: Sprint/T-Mobile approval odds closer to 50-50\" data-tweet=\"$S $TMUS - Fox Business: Sprint/T-Mobile approval odds closer to 50-50 https://seekingalpha.com/news/3451526-fox-business-sprint-t-mobile-approval-odds-closer-to-50minus-50?source=tweet\" data-url=\"https://seekingalpha.com/news/3451526-fox-business-sprint-t-mobile-approval-odds-closer-to-50minus-50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451519\" data-ts=\"1555516929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNA\" target=\"_blank\">NNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451519-navios-maritime-acquisition-announces-103_2m-sale-and-leaseback-transaction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navios Maritime Acquisition announces $103.2M sale and leaseback transaction</a></h4><ul><li>Navios Maritime Acquisition (<a href='https://seekingalpha.com/symbol/NNA' title='Navios Maritime Acquisition Corporation'>NNA</a> <font color=\"red\">-4.7%</font>) <a href=\"https://seekingalpha.com/pr/17479776-navios-maritime-acquisition-corporation-announces-103_2-million-sale-leaseback-transaction\" target=\"_blank\">completes</a> a $103.2M sale and leaseback transaction for three MR2 product tankers and two LR1 product tankers.</li><li>The proceeds have been used to refinance $82.4M of bank debt.</li><li>Navios Acquisition has an obligation to purchase the vessels at the end of seventh year for $39.7M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451519\" data-linked=\"Navios Maritime Acquisition announces $103.2M sale and leaseback transaction\" data-tweet=\"$NNA - Navios Maritime Acquisition announces $103.2M sale and leaseback transaction https://seekingalpha.com/news/3451519-navios-maritime-acquisition-announces-103_2m-sale-and-leaseback-transaction?source=tweet\" data-url=\"https://seekingalpha.com/news/3451519-navios-maritime-acquisition-announces-103_2m-sale-and-leaseback-transaction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451522\" data-ts=\"1555516834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451522-niu-technologies-and-nio-in-consumer-gainers-future-fintech-group-and-iconix-brand-group\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Niu Technologies and NIO in consumer gainers; Future FinTech Group and Iconix Brand Group among losers</a></h4><ul><li><b>Gainers: </b>Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"green\">+7%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"red\">-11%</font>. Hooker Furniture (NASDAQ:<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a>) <font color=\"red\">-9%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"red\">-8%</font>. Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"red\">-7%</font>. Funko (NASDAQ:<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451522\" data-linked=\"Niu Technologies and NIO in consumer gainers; Future FinTech Group and Iconix Brand Group among losers\" data-tweet=\"$NIU $NIO $FTFT - Niu Technologies and NIO in consumer gainers; Future FinTech Group and Iconix Brand Group among losers https://seekingalpha.com/news/3451522-niu-technologies-and-nio-in-consumer-gainers-future-fintech-group-and-iconix-brand-group?source=tweet\" data-url=\"https://seekingalpha.com/news/3451522-niu-technologies-and-nio-in-consumer-gainers-future-fintech-group-and-iconix-brand-group\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451520\" data-ts=\"1555516769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EKSO\" target=\"_blank\">EKSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451520-ekso-down-5-ahead-of-possible-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ekso down 5% ahead of possible capital raise</a></h4><ul><li>Exoskeleton developer Ekso Bionics Holdings (<a href='https://seekingalpha.com/symbol/EKSO' title='Ekso Bionics Holdings, Inc.'>EKSO</a> <font color=\"red\">-4.9%</font>) is down on below-average volume. Shares have slipped <font color=\"red\">7%</font> since Monday.</li><li>Some profit-taking is normal after an extended runup. In this case shares had rallied <font color=\"green\">102%</font> since bottoming at $1.24 on December 24, 2018.</li><li>A capital raise, however, appears necessary considering that, at year-end 2018, it had $7.7M in cash while operations consumed an average of $5.6M each quarter. It also needs to refinance ~$5.1M of debt.</li><li>In late January, it announced a <a href=\"https://seekingalpha.com/news/3427489-ekso-bionics-35-percent-announcing-jv-china\" target=\"_blank\">JV in Asia</a> that included a $10M investment in the company, although half will be deferred until product shipments begin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451520\" data-linked=\"Ekso down 5% ahead of possible capital raise\" data-tweet=\"$EKSO - Ekso down 5% ahead of possible capital raise https://seekingalpha.com/news/3451520-ekso-down-5-ahead-of-possible-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3451520-ekso-down-5-ahead-of-possible-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451507\" data-ts=\"1555514674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451507-capstone-reports-select-preliminary-4q19-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capstone reports select preliminary 4Q19 results</a></h4><div><ul><li>Capstone Turbine (<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color=\"red\">-1.1%</font>) <a href=\"https://seekingalpha.com/pr/17479571-capstone-turbine-reports-select-preliminary-q4-fiscal-2019-financial-results\" target=\"_blank\">announces</a> select preliminary financial results for 4Q19 ended March 31, 2019.</li><li>Total revenue for the quarter increased ~4% Y/Y to ~$22M.</li><li>Product revenue increased by ~11% Y/Y to ~$12.8M.</li><li>New gross product orders were ~$18M (+17% Y/Y) ; and Book-to-bill ratio estimated at 1.4:1.</li><li>Total cash and cash equivalents are estimated to be ~$29.7M as of March 31, 2019, compared to $16.7M as of December 31, 2018.</li><li>4Q19 Financial results webcast to be held June 11, 2019, at 1:45 PM PT, 4:45 PM ET.</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3451507\" data-linked=\"Capstone reports select preliminary 4Q19 results\" data-tweet=\"$CPST - Capstone reports select preliminary 4Q19 results https://seekingalpha.com/news/3451507-capstone-reports-select-preliminary-4q19-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3451507-capstone-reports-select-preliminary-4q19-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451505\" data-ts=\"1555514557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBNY\" target=\"_blank\">SBNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451505-signature-bankminus-3_3-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signature Bank -3.3% post Q1 results</a></h4><ul><li>Signature Bank (<a href='https://seekingalpha.com/symbol/SBNY' title='Signature Bank'>SBNY</a> <font color=\"red\">-3.3%</font>) reports <a href=\"https://seekingalpha.com/pr/17479146-signature-bank-reports-2019-first-quarter-results\" target=\"_blank\">Q1</a> net interest income increased 0.3% Y/Y to $319M, primarily due to growth in average interest-earning assets.</li><li>Net interest margin <font color=\"red\">declined 26 bps</font> to 3%; efficiency ratio <font color=\"red\">declined 374 bps</font> to 38.74%; Return on average total assets <font color=\"green\">improves</font> to 1.22% from 0.32%</li><li>Average cost of deposits and funds <font color=\"green\">increased 51 and 57 bps</font>, to 1.16% and 1.39%, respectively.</li><li>Total deposits stood at $36.62B; as Escrow deposits decreased $659.8M and average deposits increased $210M in Q1 2019.</li><li>Tier 1 Leverage, Common Equity Tier 1 Risk-Based, Tier 1 Risk-Based, and Total Risk-Based Capital Ratios were 9.68%, 11.97%, 11.97%, and 13.24%, respectively.</li><li>Signature Bank remains significantly above FDIC \u201cWell Capitalized\u201d standards with tangible common equity ratio was 9.29%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451315-signature-bank-misses-0_13-misses-revenue\" target=\"_blank\">Signature Bank misses by $0.13, misses on revenue</a> (Apr. 17 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451505\" data-linked=\"Signature Bank -3.3% post Q1 results\" data-tweet=\"$SBNY - Signature Bank -3.3% post Q1 results https://seekingalpha.com/news/3451505-signature-bankminus-3_3-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3451505-signature-bankminus-3_3-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451501\" data-ts=\"1555513646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451501-grocery-stocks-edge-higher-after-sector-m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery stocks edge higher after sector M&amp;A</a></h4><ul> <li>Sprouts Farmers Market (NASDAQ:<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market, Inc.'>SFM</a>) <font color=\"green\">rises 1.40%</font> and Ingles Markets (NASDAQ:<a href='https://seekingalpha.com/symbol/IMKTA' title='Ingles Markets, Incorporated'>IMKTA</a>) is <font color=\"green\">up 1.10%</font> following the buyout of Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores, Inc.'>SFS</a> <font color='green'>+20.4%</font>). Sector heavyweight Kroger (NYSE:<a href='https://seekingalpha.com/symbol/KR' title='The Kroger Co.'>KR</a>) is showing a modest gain of <font color=\"green\">0.40%</font> on a flat market day overall.</li><li>The Smart &amp; Final Stores deal went off at a level that is 12% below the 52-week share price high.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3451289-smart-and-final-plus-19-percent-pact-acquired\" target=\"_blank\">Smart &amp; Final +19% on pact to be acquired</a> (April 16)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451501\" data-linked=\"Grocery stocks edge higher after sector M&amp;A\" data-tweet=\"$SFM $IMKTA $SFS - Grocery stocks edge higher after sector M&amp;A https://seekingalpha.com/news/3451501-grocery-stocks-edge-higher-after-sector-m?source=tweet\" data-url=\"https://seekingalpha.com/news/3451501-grocery-stocks-edge-higher-after-sector-m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451500\" data-ts=\"1555513642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451500-sell-siders-trim-targets-on-unitedhealth-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders trim targets on UnitedHealth, down 2%</a></h4><ul><li>Apparently reacting to the noise from Congressional leaders on healthcare coverage, some sell-side shops have cut their fair value targets on UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"red\">-2.4%</font>) despite its <a href=\"https://seekingalpha.com/news/3450934-unitedhealth-1-percent-strong-q1\" target=\"_blank\">Q1 beat</a>.</li><li>Goldman Sachs' Stephen Tanal trimmed his target almost 5% to $291 citing, among other considerations, \"fear of policy proposals.\"</li><li>JPMorgan's Gary Taylor cut his target almost 22% to $235 citing the same political risk, especially with single-payer approaches espoused by certain Democratic presidential candidates.</li><li>Stephens' Scott Fidel is also on the bandwagon, dropping his target 8% to $270.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451500\" data-linked=\"Sell-siders trim targets on UnitedHealth, down 2%\" data-tweet=\"$UNH - Sell-siders trim targets on UnitedHealth, down 2% https://seekingalpha.com/news/3451500-sell-siders-trim-targets-on-unitedhealth-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3451500-sell-siders-trim-targets-on-unitedhealth-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451499\" data-ts=\"1555513304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451499-nymox-pharmaceutical-leads-healthcare-gainers-ionis-pharmaceuticals-and-genmark-diagnostics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox Pharmaceutical leads healthcare gainers; Ionis Pharmaceuticals and GenMark Diagnostics among losers</a></h4><ul><li><b>Gainers: </b>Nymox Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a>) <font color=\"green\">+9%</font>. Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma Corporation'>ZSAN</a>) <font color=\"green\">+9%</font>. Sierra Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a>) <font color=\"green\">+7%</font>. HEXO (NYSEMKT:<a href='https://seekingalpha.com/symbol/HEXO' title='HEXO Corp.'>HEXO</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Alector (NASDAQ:<a href='https://seekingalpha.com/symbol/ALEC' title='Alector, Inc.'>ALEC</a>) <font color=\"red\">-13%</font>. Spring Bank Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SBPH' title='Spring Bank Pharmaceuticals, Inc.'>SBPH</a>) <font color=\"red\">-13%</font>. Ionis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>) <font color=\"red\">-12%</font>. Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) <font color=\"red\">-10%</font>. GenMark Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/GNMK' title='GenMark Diagnostics, Inc.'>GNMK</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451499\" data-linked=\"Nymox Pharmaceutical leads healthcare gainers; Ionis Pharmaceuticals and GenMark Diagnostics among losers\" data-tweet=\"$NYMX $ZSAN $SRRA - Nymox Pharmaceutical leads healthcare gainers; Ionis Pharmaceuticals and GenMark Diagnostics among losers https://seekingalpha.com/news/3451499-nymox-pharmaceutical-leads-healthcare-gainers-ionis-pharmaceuticals-and-genmark-diagnostics?source=tweet\" data-url=\"https://seekingalpha.com/news/3451499-nymox-pharmaceutical-leads-healthcare-gainers-ionis-pharmaceuticals-and-genmark-diagnostics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451497\" data-ts=\"1555513028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451497-political-uncertainty-over-health-coverage-pressures-ehealth-down-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Political uncertainty over health coverage pressures eHealth, down 17%</a></h4><ul><li>Health insurance exchange operator eHealth (<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color=\"red\">-16.6%</font>) slumps on more than 50% higher volume as investors move to the sidelines in apparent reaction to the noise on healthcare policy emanating from Washington, DC.</li><li>Presidential candidate Bernie Sanders (I-VT), for example, is <a href=\"https://www.washingtonpost.com/\" target=\"_blank\">advocating </a>a Medicare-for-all system that he says the U.S. is already doing indirectly.</li><li>Fellow candidate Elizabeth Warren (D-MA) is also touting a single-payer approach.</li><li>Republicans, meanwhile, are trying their best to repeal the Affordable Care Act, an unlikely outcome considering the Democratic majority in the House. Repealing the act, known as Obamacare, would most likely be a negative for EHTH and compatriot exchange operator Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a> <font color=\"red\">-2.6%</font>).</li><li>Health insurers and managed care providers are <a href=\"https://seekingalpha.com/news/3451149-health-insurers-pressure-unh-q1-call\" target=\"_blank\">down again</a> today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451497\" data-linked=\"Political uncertainty over health coverage pressures eHealth, down 17%\" data-tweet=\"$EHTH $HIIQ - Political uncertainty over health coverage pressures eHealth, down 17% https://seekingalpha.com/news/3451497-political-uncertainty-over-health-coverage-pressures-ehealth-down-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3451497-political-uncertainty-over-health-coverage-pressures-ehealth-down-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451494\" data-ts=\"1555512563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451494-activist-chatter-sends-u-s-steel-popping\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist chatter sends U.S. Steel popping</a></h4><ul><li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color=\"green\">+2.3%</font>) is rising on heavy volume, <a href=\"https://twitter.com/OpenOutcrier/status/1118522613410750464\" target=\"_blank\">sparked by rumors</a> of potential activist movement or a trade deal.</li><li>Shares have slumped 30% since Feb. 20, culminating in two downgrades last week from BofA Merrill Lynch and Credit Suisse.</li><li>Other steel names also are in the green, including <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a> <font color=\"green\">+2.8%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color=\"green\">+4.7%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color=\"green\">+0.7%</font>, <a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color=\"green\">+0.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451494\" data-linked=\"Activist chatter sends U.S. Steel popping\" data-tweet=\"$X $AKS $MT - Activist chatter sends U.S. Steel popping https://seekingalpha.com/news/3451494-activist-chatter-sends-u-s-steel-popping?source=tweet\" data-url=\"https://seekingalpha.com/news/3451494-activist-chatter-sends-u-s-steel-popping\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451492\" data-ts=\"1555512346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451492-sprint-t-mobile-fallout-carriers-lower-spectrum-holders-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint/T-Mobile fallout: Carriers lower, spectrum holders rise</a></h4><ul>   <li>T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-3.4%</font>) and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-5.4%</font>) are sharply lower today, reflecting <a href=\"https://seekingalpha.com/news/3451259-sprint-t-mobile-lower-doj-resistance\" target=\"_blank\">yesterday's after-hours declines</a> from a <i>WSJ</i> story pointing to regulatory pushback on their $26B merger plan.</li>    <li>That news provided an immediate drag on their Big Four counterparts as well; today, AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) is <font color=\"red\">off 0.5%</font> and Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications Inc.'>VZ</a>) <font color=\"red\">down 1.8%</font>.</li>    <li>Parents of the two betrothed companies are lower: T-Mobile owner Deutsche Telekom (<a href='https://seekingalpha.com/symbol/DTEGY' title='Deutsche Telekom AG'>OTCQX:DTEGY</a>) <font color=\"red\">down 1.1%</font>, and Sprint owner SoftBank (<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group Corp.'>OTCPK:SFTBY</a>) <font color=\"red\">down 2.1%</font>.</li>    <li>Deutsche Telekom's in good shape whichever way the merger goes, suggests UBS, noting that share prices for the German incumbent don't seem to factor in much upside.</li>    <li>Meanwhile, Goldman Sachs says a failure of the deal could mean positives for those sitting on needed spectrum: Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+2.3%</font>) and Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color=\"green\">+3.6%</font>). While T-Mobile and Sprint have a deep portfolio together, none of the Big Four U.S. carriers likely have enough by themselves for 5G deployment.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451293-report-doj-opposes-t-mobile-sprint-merger-simply-untrue-ceo-legere-says\" target=\"_blank\">Report DoJ opposes T-Mobile-Sprint merger 'simply untrue,' CEO Legere says</a> (Apr. 16 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451492\" data-linked=\"Sprint/T-Mobile fallout: Carriers lower, spectrum holders rise\" data-tweet=\"$T $VZ $DTEGY - Sprint/T-Mobile fallout: Carriers lower, spectrum holders rise https://seekingalpha.com/news/3451492-sprint-t-mobile-fallout-carriers-lower-spectrum-holders-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3451492-sprint-t-mobile-fallout-carriers-lower-spectrum-holders-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451491\" data-ts=\"1555512186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MS\" target=\"_blank\">MS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451491-morgan-stanley-feels-good-loan-nii-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley feels good about loan, NII guidance</a></h4><ul><li>Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color='green'>+2.4%</font>) CFO Jonathan Pruzan says the bank feels \"very good about the mid-single-digit guidance around loan growth and NII\" even with changing U.S. interest-rate expectations and the flat yield curve.</li><li>Q1 results also showed its bond traders fared better than analysts expected amid tough markets and asset-management revenue rose.</li><li>Though investment-bank fees fell the most among Wall Street banks, Pruzan notes a turnaround in dealmaking during the quarter as evidenced by a health pipeline.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451366-morgan-stanley-plus-2_4-percent-years-slow-start-beats-consensus\" target=\"_blank\">Morgan Stanley +2.4% as year's slow start beats consensus</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451491\" data-linked=\"Morgan Stanley feels good about loan, NII guidance\" data-tweet=\"$MS - Morgan Stanley feels good about loan, NII guidance https://seekingalpha.com/news/3451491-morgan-stanley-feels-good-loan-nii-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3451491-morgan-stanley-feels-good-loan-nii-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451483\" data-ts=\"1555511857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNR\" target=\"_blank\">PNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451483-pentair-down-3-post-q1-earnings-miss-provides-q2-guidance-reaffirms-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pentair down 3% post Q1 earnings miss; provides Q2 guidance; reaffirms FY19 guidance</a></h4><div><ul><li>Pentair (<a href='https://seekingalpha.com/symbol/PNR' title='Pentair plc'>PNR</a> <font color=\"red\">-3.2%</font>) reported Q1 revenue decrease of 6% Y/Y to $688.9M, impacted by cold and wet weather.</li><li>Reported Adj. EPS of $0.43 compared to $0.49 in 1Q18.</li><li>Sales by Segments: Aquatic Systems $220.5M (-8.3% Y/Y); Filtration Solutions $239.3M (-4.9% Y/Y); and Flow Technologies $228.7M (-4.8% Y/Y).</li><li>Q1 Gross margin <font color=\"red\">declined by 40 bps</font> to 34.2%; and operating margin <font color=\"red\">decline by 290 bps</font> to 9.8%.</li><li>Net cash used for operating activities of continuing operations was $257M; and FCF usage from continuing operations was $274M.</li><li><strong>2Q19 Guidance:</strong> EPS ~$0.58-$0.61; Adj. EPS ~$0.63-$0.66 vs $0.71 consensus ; sales up ~1-2%; segment income down 5-7%; Corp. expense ~$14M-$16M; and tax rate ~22%.</li><li><strong>FY19 Guidance, reaffirmed:</strong> EPS $2.04-$2.09; Adj. EPS $2.30-$2.35; sales up ~1-2%; Corp. expense ~$60M-$65M; tax rate ~20.5%; and Capex ~$60M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451345-pentair-misses-0_02-misses-revenue\" target=\"_blank\">Pentair misses by $0.02, misses on revenue</a> (April 17)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3451483\" data-linked=\"Pentair down 3% post Q1 earnings miss; provides Q2 guidance; reaffirms FY19 guidance\" data-tweet=\"$PNR - Pentair down 3% post Q1 earnings miss; provides Q2 guidance; reaffirms FY19 guidance https://seekingalpha.com/news/3451483-pentair-down-3-post-q1-earnings-miss-provides-q2-guidance-reaffirms-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3451483-pentair-down-3-post-q1-earnings-miss-provides-q2-guidance-reaffirms-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451484\" data-ts=\"1555511814\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451484-novartis-data-on-sma-gene-therapy-pressures-ionis-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novartis data on SMA gene therapy pressures Ionis, down 11%</a></h4><ul><li>Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"red\">-11.3%</font>) is down on average volume in apparent response to late-stage data on Novartis unit AveVix's SMA Type 1 gene therapy Zolgensma <a href=\"https://seekingalpha.com/news/3451382-avexis-zolgensma-shows-positive-effect-late-stage-sma-study\" target=\"_blank\">announced</a> this morning that investors appear to regard as a threat to SPINRAZA.</li><li>Royalties from SPINRAZA (nusinersen), out-licensed to Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"green\">+0.1%</font>), accounted for almost 37% of Q4 revenues ($70.2M/$192.1).</li><li>Another (minor) item of note is Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"red\">-0.1%</font>) disclosure that it will not be updating on a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03342053?term=rg6042&amp;rank=3\" target=\"_blank\">Phase 2 clinical trial</a> evaluating Huntington's disease candidate RG6042 at the American Academy of Neurology meeting in early May. Ionis <a href=\"https://seekingalpha.com/news/3317451-ionis-pharmaceuticals-licenses-ionis-htt-rx-roche-following-successful-phase-1-2a-study\" target=\"_blank\">out-licensed</a> the candidate, known as IONIS-HTTrx at the time, to Roche in December 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451484\" data-linked=\"Novartis data on SMA gene therapy pressures Ionis, down 11%\" data-tweet=\"$IONS $BIIB $RHHBY - Novartis data on SMA gene therapy pressures Ionis, down 11% https://seekingalpha.com/news/3451484-novartis-data-on-sma-gene-therapy-pressures-ionis-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3451484-novartis-data-on-sma-gene-therapy-pressures-ionis-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451482\" data-ts=\"1555511553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451482-oil-inventories-in-line-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil inventories in-line with consensus</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-1.4</strong><strong>M</strong> barrels vs. -1.2M consensus, +7.0M last week.</li><li>Gasoline <strong>-1.2M</strong> barrels vs. -2.1M consensus, -7.7M last week.</li><li>Distillates<strong> -0.4</strong><strong>M</strong> barrels vs. -0.8M consensus, -0.1M last week.</li><li>Futures <font color=\"green\">+0.11%</font> to $64.12.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451482\" data-linked=\"Oil inventories in-line with consensus\" data-tweet=\"$USO $OIL $UCO - Oil inventories in-line with consensus https://seekingalpha.com/news/3451482-oil-inventories-in-line-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3451482-oil-inventories-in-line-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451481\" data-ts=\"1555511509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451481-citi-top-pick-marvell-gets-pt-boost-mrvlplus-3_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi top pick Marvell gets PT boost; MRVL +3.5%</a></h4><ul><li>Citi strengthens its bull stance on Marvell (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group Ltd.'>MRVL</a>) by raising the target from $22 to $28 on increasing confidence in the 5G positioning, strengthening storage fundamentals, and growing M&amp;A appeal.</li><li>MRVL remains a Citi top pick in specialty semis with analyst Atif Malik saying, \"We view MRVL as the best way of playing the second wave of 5G cycle spend.\"</li><li>Marvell shares are <font color=\"green\">up 3.5%</font> to $24.86 on a strong day for semis after the Apple-Qualcomm <a href=\"https://seekingalpha.com/news/3451208-qualcomm-apple-drop-litigation-qcom-plus-14_7-percent\" target=\"_blank\">legal truce</a> and Intel's 5G <a href=\"https://seekingalpha.com/news/3451414-intel-drops-5g-phones-qualcomm-apple-truce\" target=\"_blank\">phone modem</a> exit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451481\" data-linked=\"Citi top pick Marvell gets PT boost; MRVL +3.5%\" data-tweet=\"$MRVL - Citi top pick Marvell gets PT boost; MRVL +3.5% https://seekingalpha.com/news/3451481-citi-top-pick-marvell-gets-pt-boost-mrvlplus-3_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3451481-citi-top-pick-marvell-gets-pt-boost-mrvlplus-3_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451480\" data-ts=\"1555511486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMC\" target=\"_blank\">OMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451480-omnicom-near-two-year-high-in-continued-post-earnings-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omnicom near two-year-high in continued post-earnings rally</a></h4><ul>   <li>Shares in Omnicom (<a href=\"http://seekingalpha.com/symbol/OMC\" target=\"_blank\">OMC</a> <font color=\"green\">+3%</font>) are at a near-two-year high, continuing a move up after <a href=\"https://seekingalpha.com/news/3451090-52-week-high-omicom-profit-beat\" target=\"_blank\">yesterday's profit beat</a>, as Barclays takes off its Sell sign and upgrades to Equal Weight.</li>    <li>The firm boosted its price target to $84 from $76; shares are up to $83.67 today on NYSE.</li>    <li>Shares are now <font color=\"green\">up 18.4%</font> over the past six months after moving <font color=\"green\">up 8.4%</font> in the past week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451480\" data-linked=\"Omnicom near two-year-high in continued post-earnings rally\" data-tweet=\"$OMC - Omnicom near two-year-high in continued post-earnings rally https://seekingalpha.com/news/3451480-omnicom-near-two-year-high-in-continued-post-earnings-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3451480-omnicom-near-two-year-high-in-continued-post-earnings-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451479\" data-ts=\"1555511383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOFT\" target=\"_blank\">HOFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451479-headwinds-warning-whacks-hooker-furniture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Headwinds warning whacks Hooker Furniture</a></h4><ul> <li>Hooker Furniture (NASDAQ:<a href='https://seekingalpha.com/symbol/HOFT' title='Hooker Furniture Corporation'>HOFT</a>) is <font color=\"red\">down 9.44%</font> after warning on soft demand in the first part of FQ1 due to what it calls short-term headwinds.</li> <li>\"We believe our diversified business model allows us to perform well through economic fluctuations, and we are making the investments needed in products, programs, systems and people to continue to perform at a high level,\" maintains the retailer.</li> <li>Shares of Hooker Furniture trade at a three-week low.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451273-hooker-furniture-beats-0_19-beats-revenue\" target=\"_blank\">Hooker Furniture beats by $0.19, beats on revenue</a> (April 16)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451282-hooker-furniture-slightly-post-q4-earnings-beat\" target=\"_blank\">Hooker Furniture up slightly post Q4 earnings beat</a> (April 16)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451479\" data-linked=\"Headwinds warning whacks Hooker Furniture\" data-tweet=\"$HOFT - Headwinds warning whacks Hooker Furniture https://seekingalpha.com/news/3451479-headwinds-warning-whacks-hooker-furniture?source=tweet\" data-url=\"https://seekingalpha.com/news/3451479-headwinds-warning-whacks-hooker-furniture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451476\" data-ts=\"1555510928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451476-micronplus-1_8-on-bullish-nand-dram-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron +1.8% on more bullish NAND/DRAM report</a></h4><ul><li>Cleveland Research sees DRAM pricing getting \"incrementally better\" while NAND could turn around \"sooner than previously expected.\"</li><li>The firm thinks DRAM and NAND have a more favorable 2020 setup due to \"signs of inventory improving, plans for accelerating CSP orders, seasonal demand in H2, and the impact from capex/supply cuts.\"</li><li>NAND could bottom in the February quarter and DRAM in the May quarter of next year.</li><li>Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a>) shares are <font color=\"green\">up 1.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451476\" data-linked=\"Micron +1.8% on more bullish NAND/DRAM report\" data-tweet=\"$MU - Micron +1.8% on more bullish NAND/DRAM report https://seekingalpha.com/news/3451476-micronplus-1_8-on-bullish-nand-dram-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3451476-micronplus-1_8-on-bullish-nand-dram-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451473\" data-ts=\"1555510538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BK\" target=\"_blank\">BK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451473-bny-mellonminus-8_5-amid-ceos-yield-curve-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BNY Mellon -8.5% amid CEO&#39;s yield-curve warning</a></h4><ul><li>Bank of New York Mellon (NYSE:<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a>)<font color=\"red\"> drops 8.5%</font> after its CEO warns that the yield curve will hurt revenue growth for several quarters to come.</li><li>Weak revenue more than offset the bank's efforts to manage expenses,<a href=\"https://www.bloomberg.com/news/articles/2019-04-17/bank-of-new-york-mellon-tumbles-as-yield-curve-will-keep-hurting\" target=\"_blank\"> writes</a> Credit Suisse analyst Roth Katzke. Net interest income and fees trailed forecast as NII was hit by deposit run-off.</li><li>Jefferies's Ken Usdin writes that NII will likely \"remain subdued,\" adding that \"expense control remained solid, but operating leverage was absent.\"</li><li>The revenue trends experienced by BNY Mellon may also appear at custodial bank rivals State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>) and Northern Trust, he writes.</li><li>State Street <font color=\"red\">sinks 3.4%</font>, while Northern Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRS' title='Northern Trust Corporation'>NTRS</a>) <font color=\"red\">slides 2.7%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451335-bny-mellon-hurt-changing-mix-cost-deposits\" target=\"_blank\">BNY Mellon hurt by changing mix and cost of deposits</a> (April 17)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451473\" data-linked=\"BNY Mellon -8.5% amid CEO&#39;s yield-curve warning\" data-tweet=\"$BK $STT $NTRS - BNY Mellon -8.5% amid CEO&#39;s yield-curve warning https://seekingalpha.com/news/3451473-bny-mellonminus-8_5-amid-ceos-yield-curve-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3451473-bny-mellonminus-8_5-amid-ceos-yield-curve-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451472\" data-ts=\"1555510499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGD\" target=\"_blank\">NGD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451472-new-gold-gets-federal-go-ahead-for-c-1-b-blackwater-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Gold gets federal go-ahead for C$1.B Blackwater project</a></h4><ul><li>New Gold (<a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc.'>NGD</a> <font color='green'>+4.2%</font>) says it received <a href=\"http://www.mining.com/new-gold-gets-green-light-1-b-blackwater-gold-project-bc/\" target=\"_blank\">conditional approval</a> from the federal Minister of Environment and Climate Change for its 100% owned C$1.8B Blackwater gold project proposal in British Columbia.</li><li>The ministry says its assessment concluded the project likely would not cause  significant adverse environmental effects when mitigation measures are  taken into account.</li><li>Currently in the exploration phase, Blackwater has 8.2M oz. of  gold in proven and probable mineral reserve, and 60.8M oz. of silver; the project is expected to produce 60K mt/day of gold and silver ore over a mine life of 17 years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451472\" data-linked=\"New Gold gets federal go-ahead for C$1.B Blackwater project\" data-tweet=\"$NGD - New Gold gets federal go-ahead for C$1.B Blackwater project https://seekingalpha.com/news/3451472-new-gold-gets-federal-go-ahead-for-c-1-b-blackwater-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3451472-new-gold-gets-federal-go-ahead-for-c-1-b-blackwater-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451470\" data-ts=\"1555510249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRTN\" target=\"_blank\">MRTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451470-marten-transportplus-8_4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marten Transport +8.4% post Q1 results</a></h4><ul><li>Marten Transport (<a href='https://seekingalpha.com/symbol/MRTN' title='Marten Transport, Ltd.'>MRTN</a> <font color=\"green\">+8.4%</font>) reports <a href=\"https://seekingalpha.com/pr/17478772-marten-transport-announces-first-quarter-results\" target=\"_blank\">Q1</a> revenue growth of 6.5% Y/Y to 199M.</li><li>Segment revenue: Truckload $91.72M (-1.4% Y/Y); Dedicated $57.7M (+18.2% Y/Y); Intermodal $23M (-6.8% Y/Y) &amp; Brokerage of $26.6M (+30% Y/Y).</li><li>Operating margin: Total operating <font color=\"red\">declined 160 bps</font> to 91.1%; Truckload <font color=\"red\">declined 90 bps</font> to 91.8%; Dedicated declined 450 bps to 90.4%; Intermodal declined 170 bps to 89.6% &amp; Brokerage <font color=\"red\">declined 210 bps</font> to 91.5%.</li><li>Average revenue, net of fuel surcharges, per tractor per week: Truckload $3.86M; Dedicated $3.38M.</li><li>Average tractors: Truckload 1,616; Dedicated 1,125 &amp; Intermodal 87.</li><li>Average miles per trip: Truckload 562; Dedicated 322.</li><li>\u201cWe are pleased to report our continued strong top- and bottom-line results for this quarter, which produced our best-ever first-quarter operating revenue, operating income and net income.\u201d said Randolph L. Marten, Chairman and CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3451224-marten-transport-beats-0_01-beats-revenue\" target=\"_blank\">Marten Transport beats by $0.01, beats on revenue</a> (Apr. 16 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3451470\" data-linked=\"Marten Transport +8.4% post Q1 results\" data-tweet=\"$MRTN - Marten Transport +8.4% post Q1 results https://seekingalpha.com/news/3451470-marten-transportplus-8_4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3451470-marten-transportplus-8_4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451467\" data-ts=\"1555510025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451467-canopy-growth-and-aurora-cannabis-get-new-sell-side-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth and Aurora Cannabis get a new sell-side bull</a></h4><ul><li>\"We think Canopy (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"green\">+1.8%</font>) is one of the few companies in pole-position to be a long-term leader in the global cannabis sector,\" says Bank of America, launching coverage with a Buy rating and $52 price target (about <font color=\"green\">25% upside</font>).</li><li>The team also starts coverage on Aurora Cannabis (<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+1%</font>) with a Buy. The $11 price target is roughly <font color=\"green\">25% upside</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451467\" data-linked=\"Canopy Growth and Aurora Cannabis get a new sell-side bull\" data-tweet=\"$CGC $ACB - Canopy Growth and Aurora Cannabis get a new sell-side bull https://seekingalpha.com/news/3451467-canopy-growth-and-aurora-cannabis-get-new-sell-side-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3451467-canopy-growth-and-aurora-cannabis-get-new-sell-side-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451462\" data-ts=\"1555509614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUOT\" target=\"_blank\">QUOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451462-quotient-techplus-5_7-craig-hallum-restarts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quotient Tech +5.7% as Craig-Hallum restarts at Buy</a></h4><ul>   <li>Quotient Technology (NYSE:<a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a>) is <font color=\"green\">up 5.7%</font> after a reinstatement by Craig-Hallum at Buy, adding to a chorus of a half-dozen bulls.</li>    <li>The firm set a price target to $20, implying 109% upside from current pricing.</li>    <li>Consensus expectations for <a href=\"https://seekingalpha.com/symbol/QUOT/earnings\" target=\"_blank\">upcoming earnings</a> are for the company to record EPS of -$0.05 on revenues of $95.6M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451462\" data-linked=\"Quotient Tech +5.7% as Craig-Hallum restarts at Buy\" data-tweet=\"$QUOT - Quotient Tech +5.7% as Craig-Hallum restarts at Buy https://seekingalpha.com/news/3451462-quotient-techplus-5_7-craig-hallum-restarts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3451462-quotient-techplus-5_7-craig-hallum-restarts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451461\" data-ts=\"1555509593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451461-longbow-hits-semi-sidelines-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Longbow hits semi sidelines ahead of earnings</a></h4><ul><li>Longbow downgrades a slate of semi names from Buy to Neutral: Diodes (<a href='https://seekingalpha.com/symbol/DIOD' title='Diodes Incorporated'>DIOD</a> <font color='red'>-2.3%</font>), Littelfuse (<a href='https://seekingalpha.com/symbol/LFUS' title='Littelfuse, Inc.'>LFUS</a> <font color='red'>-0.5%</font>), ON Semi (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+1%</font>), and Texas Instruments (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Incorporated'>TXN</a> <font color='green'>+0.3%</font>).</li><li>Expected earnings dates: Texas Instruments on April 23, ON Semi on April 29, Littelfuse on May 1, Diodes on May 14.</li><li>Semi names are in the green today after yesterday's Apple-Qualcomm <a href=\"https://seekingalpha.com/news/3451208-qualcomm-apple-drop-litigation-qcom-plus-14_7-percent\" target=\"_blank\">settlement</a>, which pushed the semi index to a record high.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451461\" data-linked=\"Longbow hits semi sidelines ahead of earnings\" data-tweet=\"$TXN $ON $LFUS - Longbow hits semi sidelines ahead of earnings https://seekingalpha.com/news/3451461-longbow-hits-semi-sidelines-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3451461-longbow-hits-semi-sidelines-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451447\" data-ts=\"1555508031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451447-analysts-bullish-on-qualcomm-after-apple-truce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts bullish on Qualcomm after Apple truce</a></h4><ul><li>Stifel leaves Qualcomm's (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) sidelines for a Buy rating ($100 PT) and says management's $2/share earnings increase projection suggests no or only a slight discount to QCOM's licensing fee.</li><li>Evercore steps from In-Line to Outperform calling QCOM shares \"investable\" again after the <a href=\"https://seekingalpha.com/news/3451208-qualcomm-apple-drop-litigation-qcom-plus-14_7-percent\" target=\"_blank\">Apple settlement</a>. The firm raises its target from $60 to $90.</li><li>JPMorgan cites Qualcomm's \"strong 5G positioning\" in its move from Neutral to Overweight.</li><li>Both Stifel and JPMorgan said that the agreement suggested Intel's 5G modems weren't ready for the 2020 iPhone, which Intel <a href=\"https://seekingalpha.com/news/3451414-intel-drops-5g-phones-qualcomm-apple-truce\" target=\"_blank\">later confirmed</a> by canceling its 5G smartphone plans.</li><li>Qualcomm shares are <font color=\"green\">up 14.2%</font> to $80.47.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451447\" data-linked=\"Analysts bullish on Qualcomm after Apple truce\" data-tweet=\"$QCOM - Analysts bullish on Qualcomm after Apple truce https://seekingalpha.com/news/3451447-analysts-bullish-on-qualcomm-after-apple-truce?source=tweet\" data-url=\"https://seekingalpha.com/news/3451447-analysts-bullish-on-qualcomm-after-apple-truce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451443\" data-ts=\"1555507735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PDD\" target=\"_blank\">PDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451443-pinduoduoplus-1_7-keybanc-initiates-overweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinduoduo +1.7% as KeyBanc initiates at Overweight</a></h4><ul>   <li>Pinduoduo ADRs (NASDAQ:<a href='https://seekingalpha.com/symbol/PDD' title='Pinduoduo Inc.'>PDD</a>) are <font color=\"green\">1.7% higher</font> premarket on a start at Overweight at KeyBanc.</li>    <li>Analyst Hans Chung and team have set a price target of $32, implying 42.2% upside.</li>    <li>With a choppy 2019 so far, shares are <font color=\"red\">down 12.9%</font> over the past month, but <font color=\"green\">up 4.1%</font> over the past six months.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3450554-pinduoduo-gains-new-bull\" target=\"_blank\">Pinduoduo gains on new bull</a> (Apr. 15 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451443\" data-linked=\"Pinduoduo +1.7% as KeyBanc initiates at Overweight\" data-tweet=\"$PDD - Pinduoduo +1.7% as KeyBanc initiates at Overweight https://seekingalpha.com/news/3451443-pinduoduoplus-1_7-keybanc-initiates-overweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3451443-pinduoduoplus-1_7-keybanc-initiates-overweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451440\" data-ts=\"1555507515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451440-celsion-nabs-new-patent-for-thermodox-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celsion nabs new patent for Thermodox in U.S.</a></h4><ul> <li>The USPTO has <a href=\"https://seekingalpha.com/pr/17479419-celsion-corporation-announces-issuance-new-patent-thermodox\" target=\"_blank\">granted</a> Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) U.S. Patent No. 10,251,901 B2 \u2013 <em>Thermosensitive Nanoparticle Formulations and Method of Making the Same</em>, which is directly applicable to the method of treating cancer using a new ThermoDox formulation.</li><li>The claim covers a method for preparing (as well as the composition of) a doxorubicin sulfate temperature-sensitive liposome and extends coverage time over ThermoDox\u2019s current patent portfolio to 2033.</li>        <li>This new patent strengthens the coverage of ThermoDox, currently in Phase III development for the treatment of primary liver cancer, also known as hepatocellular carcinoma.</li><li>Shares are up <font color=\"green\">2%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3451440\" data-linked=\"Celsion nabs new patent for Thermodox in U.S.\" data-tweet=\"$CLSN - Celsion nabs new patent for Thermodox in U.S. https://seekingalpha.com/news/3451440-celsion-nabs-new-patent-for-thermodox-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3451440-celsion-nabs-new-patent-for-thermodox-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451437\" data-ts=\"1555507277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451437-qcom-abb-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QCOM, ABB among premarket gainers</a></h4><ul><li>Smart &amp; Final Stores (NYSE:<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores, Inc.'>SFS</a>) <font color=\"green\">+20%</font> on being <a href=\"https://seekingalpha.com/news/3451289-smart-and-final-plus-19-percent-pact-acquired\" target=\"_blank\">acquired</a>.</li><li>QUALCOMM (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='QUALCOMM Incorporated'>QCOM</a>) <font color=\"green\">+13%</font>.</li><li>Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin Limited'>UXIN</a>) <font color=\"green\">+12%</font>.</li><li>Quotient Technology (NYSE:<a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a>) <font color=\"green\">+10%</font>.</li><li>Hollysys Automation Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLI' title='Hollysys Automation Technologies Ltd.'>HOLI</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/pr/17479223-hollysys-announces-withdrawal-public-offering-ordinary-shares\" target=\"_blank\">withdrawal</a> of public offering of ordinary shares.</li><li>ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/pr/17479738-toughbuilt-announces-launch-new-technology-based-business-segment-focused-exclusively-mobile\" target=\"_blank\">launch</a> of its technology business segment.</li><li>ABB (NYSE:<a href='https://seekingalpha.com/symbol/ABB' title='ABB Ltd'>ABB</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3451309-abb-beats-0_03-beats-revenue\" target=\"_blank\">Q1 results</a>.</li><li>ZK International (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/news/3451331-zk-international-anticipates-revenue-growth-25-percent-fy2019\" target=\"_blank\">anticipating</a> revenue growth of 25% for FY2019.</li><li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"green\">+6%</font>.</li><li>TherapeuticsMD (NASDAQ:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD, Inc.'>TXMD</a>) <font color=\"green\">+6%</font> as <a href=\"https://seekingalpha.com/news/3451394-therapeuticsmds-bijuva-now-available-u-s\" target=\"_blank\">BIJUVA</a> is now available in U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451437\" data-linked=\"QCOM, ABB among premarket gainers\" data-tweet=\"$SFS $QCOM $UXIN - QCOM, ABB among premarket gainers https://seekingalpha.com/news/3451437-qcom-abb-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451437-qcom-abb-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451436\" data-ts=\"1555507251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUBI\" target=\"_blank\">RUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451436-rubicon-projectplus-4_1-b-riley-starts-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rubicon Project +4.1% as B. Riley starts at Buy</a></h4><ul>   <li>The Rubicon Project (NYSE:<a href='https://seekingalpha.com/symbol/RUBI' title='the Rubicon Project, Inc.'>RUBI</a>) is <font color=\"green\">up 4.1%</font> premarket after an initiation at Buy by B. Riley FBR.</li>    <li>The firm's Lee Krowl set a price target at $9, an above-average target that implies 50% upside.</li>    <li>The company's set to <a href=\"https://seekingalpha.com/symbol/RUBI/earnings\" target=\"_blank\">report earnings</a> after the close on May 1; it's expected to log EPS of -$0.19 on revenues of $31.17M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451436\" data-linked=\"Rubicon Project +4.1% as B. Riley starts at Buy\" data-tweet=\"$RUBI - Rubicon Project +4.1% as B. Riley starts at Buy https://seekingalpha.com/news/3451436-rubicon-projectplus-4_1-b-riley-starts-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3451436-rubicon-projectplus-4_1-b-riley-starts-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451433\" data-ts=\"1555506951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIX\" target=\"_blank\">ANIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451433-anixa-bio-nabs-patent-for-car-t-technology-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anixa Bio nabs patent for CAR-T technology in U.S.</a></h4><ul> <li>The USPTO has <a href=\"https://seekingalpha.com/pr/17479282-us-patent-and-trademark-office-issues-patent-anixa-biosciences-car-t-cancer-treatment\" target=\"_blank\">issued</a> Anixa Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ANIX' title='Anixa Biosciences, Inc.'>ANIX</a>) Patent No. 10,259,855, covering Company's CAR-T cancer treatment technology.</li>                  <li>The patent is titled \"METHODS AND COMPOSITIONS FOR TREATING CANCER.\" The patent is assigned to The Wistar Institute and Anixa Biosciences' majority-owned subsidiary, Certainty Therapeutics, is the exclusive, world-wide licensee.</li><li>Shares are up <font color=\"green\">4%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451433\" data-linked=\"Anixa Bio nabs patent for CAR-T technology in U.S.\" data-tweet=\"$ANIX - Anixa Bio nabs patent for CAR-T technology in U.S. https://seekingalpha.com/news/3451433-anixa-bio-nabs-patent-for-car-t-technology-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3451433-anixa-bio-nabs-patent-for-car-t-technology-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451428\" data-ts=\"1555506631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451428-bk-and-s-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BK and S among premarket losers</a></h4><ul><li>Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-35%</font>.</li><li>Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a>) <font color=\"red\">-12%</font>.</li><li>Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future FinTech Group Inc.'>FTFT</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3451278-future-fintech-file-late-stocks-minus-4_5-percent\" target=\"_blank\">late</a> filing.</li><li>MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='MicroVision, Inc.'>MVIS</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3451363-microvision-beats-0_01-revenue-line\" target=\"_blank\">Q1 earnings</a>.</li><li>The Bank of New York Mellon (NYSE:<a href='https://seekingalpha.com/symbol/BK' title='The Bank of New York Mellon Corporation'>BK</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3451330-bank-new-york-mellon-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) <font color=\"red\">-6%</font> on DOJ <a href=\"https://seekingalpha.com/news/3451259-sprint-t-mobile-lower-doj-resistance\" target=\"_blank\">resistance</a> for merger deal with T-Mobile.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3451428\" data-linked=\"BK and S among premarket losers\" data-tweet=\"$YRIV $MRKR $FTFT - BK and S among premarket losers https://seekingalpha.com/news/3451428-bk-and-s-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3451428-bk-and-s-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451426\" data-ts=\"1555506622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPWR\" target=\"_blank\">IPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451426-ideal-power-to-sell-power-conversion-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ideal Power to sell power conversion business</a></h4><ul><li>Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"green\">+7.9%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17479352-pathion-inc-acquires-ideal-power-s-power-conversion-business-unit-technology\" target=\"_blank\">agreeing to sell</a> its Power Conversion Systems business and Power Packet Switching Architecture technology to Pathion Holdings for a <a href=\"https://www.sec.gov/Archives/edgar/data/1507957/000114420419019972/tv519043_8k.htm\" target=\"_blank\">combination of cash and stock</a>.</li><li>IPWR says the sale will allow it to focus on the commercialization of its proprietary B-TRAN technology.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451426\" data-linked=\"Ideal Power to sell power conversion business\" data-tweet=\"$IPWR - Ideal Power to sell power conversion business https://seekingalpha.com/news/3451426-ideal-power-to-sell-power-conversion-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3451426-ideal-power-to-sell-power-conversion-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451424\" data-ts=\"1555506518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVIV\" target=\"_blank\">NVIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451424-invivo-up-2-premarket-on-new-neuro-spinal-scaffold-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InVivo up 2% premarket on new Neuro-Spinal Scaffold data</a></h4><ul><li>Thinly traded nano cap InVivo Therapeutics Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp.'>NVIV</a>) is up up <font color=\"green\">2%</font> premarket on light volume on the heels of <a href=\"https://seekingalpha.com/pr/17479385-invivo-therapeutics-announces-presentation-twelve-month-results-inspire-study-investigational\" target=\"_blank\">12-month data</a> from the <a href=\"https://clinicaltrials.gov/ct2/show/NCT02138110?term=invivo+therapeutics&amp;rank=2\" target=\"_blank\">INSPIRE </a>study of its Neuro-Spinal Scaffold in patients with complete thoracic spinal cord injury. The results were presented at the American Association of Neurological Surgeons Annual Meeting in San Diego.</li><li>Six of seven patients who reached the six-month primary endpoint visit were evaluated a month 12. All six experienced an ASIA Impairment Scale &#40;AIS&#41; conversion (at least a one level improvement from baseline) at month 6 and remained converted at month 12.</li><li>The estimated completion date of the study is August 2024.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451424\" data-linked=\"InVivo up 2% premarket on new Neuro-Spinal Scaffold data\" data-tweet=\"$NVIV - InVivo up 2% premarket on new Neuro-Spinal Scaffold data https://seekingalpha.com/news/3451424-invivo-up-2-premarket-on-new-neuro-spinal-scaffold-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3451424-invivo-up-2-premarket-on-new-neuro-spinal-scaffold-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451422\" data-ts=\"1555506269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451422-avinger-up-11-premarket-on-new-u-s-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avinger up 11% premarket on new U.S. patent</a></h4><ul> <li>The USPTO has <a href=\"https://seekingalpha.com/pr/17479495-avinger-announces-issuance-new-u-s-patent-receives-notice-allowance-five-additional-u-s\" target=\"_blank\">issued</a> Avinger (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger, Inc.'>AVGR</a>) a new patent related to the Company's optical coherence tomography &#40;OCT&#41; intravascular imaging system.</li><li>The Patent No. 10,244,934, titled \"Atherectomy Catheter Drive Assemblies,\" issued on April 2, covers drive assemblies, which are a key component of the Company's proprietary OCT intravascular imaging system.</li> <li>These assemblies are currently used in the Company's Pantheris image-guided atherectomy systems and are integral to the Company's pipeline products.</li><li>The Company has also received notice of allowance for five additional patent applications.</li><li>Shares are up <font color=\"green\">11%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451422\" data-linked=\"Avinger up 11% premarket on new U.S. patent\" data-tweet=\"$AVGR - Avinger up 11% premarket on new U.S. patent https://seekingalpha.com/news/3451422-avinger-up-11-premarket-on-new-u-s-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/3451422-avinger-up-11-premarket-on-new-u-s-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451416\" data-ts=\"1555505873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBRX\" target=\"_blank\">MBRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451416-moleculin-up-19-premarket-on-encouraging-annamycin-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Moleculin up 19% premarket on encouraging annamycin data</a></h4><ul><li>Moleculin Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/MBRX' title='Moleculin Biotech, Inc.'>MBRX</a>) <a href=\"https://seekingalpha.com/pr/17479345-moleculin-announces-significant-discovery-lung-cancer-models\" target=\"_blank\">announces</a> that its ongoing sponsored research at The University of Texas MD Anderson Cancer Center has now demonstrated that Annamycin is able to significantly improve survival in an aggressive form of triple negative breast cancer metastasized to the lungs in animal models.</li><li>Shares are up <font color=\"green\">19%</font> premarket.</li>                   </ul><div class=\"tiny-share-widget\" data-id=\"3451416\" data-linked=\"Moleculin up 19% premarket on encouraging annamycin data\" data-tweet=\"$MBRX - Moleculin up 19% premarket on encouraging annamycin data https://seekingalpha.com/news/3451416-moleculin-up-19-premarket-on-encouraging-annamycin-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3451416-moleculin-up-19-premarket-on-encouraging-annamycin-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451414\" data-ts=\"1555505624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451414-intel-drops-5g-phones-after-qualcomm-apple-truce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel drops 5G phones after Qualcomm-Apple truce</a></h4><ul><li>Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) \"does not expect to launch 5G modem products in the smartphone space, including those originally planned for launches in 2020.\"</li><li>Apple's long-rumored 5G iPhone was expected to release in 2020 with an Intel modem.</li><li>Intel <a href=\"https://seekingalpha.com/pr/17479027-intel-exit-5g-smartphone-modem-business-focus-5g-efforts-network-infrastructure-data-centric\" target=\"_blank\">says</a> it will instead focus on 4G and 5G modems for PCs, IoT, and other data-centric devices.</li><li>Earlier this month, UBS analyst Timothy Accuri <a href=\"https://seekingalpha.com/news/3448154-5g-iphone-2020\" target=\"_blank\">suggested</a> Apple wouldn't release its 5G phone in 2020 partly due to Intel not being ready to supply a compatible processing chip.</li><li>Intel <a href=\"https://seekingalpha.com/news/3448545-intels-5g-modem-still-coming-2020\" target=\"_blank\">refuted the note </a>a day later and said it remained on track to supply its XMM 8160 5G modems for 2020 devices.</li><li>Apple was relying on Intel modems due to a long-standing legal battle with Qualcomm, which <a href=\"https://seekingalpha.com/news/3451208-qualcomm-apple-drop-litigation-qcom-plus-14_7-percent\" target=\"_blank\">ended yesterday</a> in a global settlement.</li><li>Intel shares are <font color=\"green\">up 4.5%</font> pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451414\" data-linked=\"Intel drops 5G phones after Qualcomm-Apple truce\" data-tweet=\"$INTC - Intel drops 5G phones after Qualcomm-Apple truce https://seekingalpha.com/news/3451414-intel-drops-5g-phones-after-qualcomm-apple-truce?source=tweet\" data-url=\"https://seekingalpha.com/news/3451414-intel-drops-5g-phones-after-qualcomm-apple-truce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451413\" data-ts=\"1555505605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASI\" target=\"_blank\">CASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451413-casi-in-licences-cancer-candidate-shares-up-5-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CASI in-licences cancer candidate, shares up 5% premarket</a></h4><ul> <li>CASI Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals, Inc.'>CASI</a>) has <a href=\"https://seekingalpha.com/pr/17479265-casi-pharmaceuticals-licenses-exclusive-worldwide-rights-novel-anti-cd38-monoclonal-antibody\" target=\"_blank\">signed</a> a license agreement for exclusive worldwide rights to investigational anti-CD38 monoclonal antibody (Mab) TSK011010 program from Black Belt Therapeutics Limited.</li>                  <li>Under the terms of agreement, CASI will pay an upfront payment of \u20ac5M and an equity investment of \u20ac2M, as well as certain milestone and royalty payments.</li> <li>TSK011010 is at the IND/IMPD submission stage of development, with Phase 1 trials expected to start in late 2019/early 2020.</li><li>Shares are up <font color=\"green\">5%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3451413\" data-linked=\"CASI in-licences cancer candidate, shares up 5% premarket\" data-tweet=\"$CASI - CASI in-licences cancer candidate, shares up 5% premarket https://seekingalpha.com/news/3451413-casi-in-licences-cancer-candidate-shares-up-5-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3451413-casi-in-licences-cancer-candidate-shares-up-5-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3451412\" data-ts=\"1555505337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDOC\" target=\"_blank\">TDOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3451412-stephens-sees-43-upside-in-teladoc-shares-ahead-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens sees 43% upside in Teladoc, shares ahead 4% premarket</a></h4><ul><li>Teladoc (NYSE:<a href='https://seekingalpha.com/symbol/TDOC' title='Teladoc Health, Inc.'>TDOC</a>) is up <font color=\"green\">4%</font> premarket on light volume on the heels of a bullish call (Overweight/$75) at Stephens who sees \"considerable growth\" in telehealth.</li><li>Per Bloomberg, 17 of 19 shops have Buy ratings on the stock with an average price target of $81 (54% upside).</li><li>Consensus Q1 view is a loss/share of ($0.44) on revenue of $128.1M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3451412\" data-linked=\"Stephens sees 43% upside in Teladoc, shares ahead 4% premarket\" data-tweet=\"$TDOC - Stephens sees 43% upside in Teladoc, shares ahead 4% premarket https://seekingalpha.com/news/3451412-stephens-sees-43-upside-in-teladoc-shares-ahead-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3451412-stephens-sees-43-upside-in-teladoc-shares-ahead-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}